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ABSTRACT

The main goal ofthis study was to discover polymer candidates which can cross
link and as an imprinted template with quadruplex structures for nucleic acid applications
such as recognition and transfection. Nucleic acids are classified as macro-biopolymers
which are central to the functioning of organisms. Nucleic acid polymers have many
applications in different fields such as biotechnology, medicine and nanomaterials. One
application, gene therapy, can provide great opportunities for treating diseases from
genetic disorders to cancer. Polymers are one non-viral delivery vector for gene therapy.
Cationic polymers have advantages in gene delivery and appear to have promising
potential in the treatment of diseases.
Polyethylenimine (PEl), a commercial cationic polymer, is available in bulk
quantities. PEl has been widely used for non-viral transfection in vitro and in vivo and
also been proven to be an efficient vector for use in gene delivery and other biological
areas. lsophthalaldehyde, a cross-linker, was found to be effective in use with PEl. In an
attempt to make cross-linked PEl nanoparticles for nucleic acid gene delivery, we cross
linked branched (25K) PEl with isophthalaldehyde. In situ IH NMR, QELS light
scattering and UV-Vis data are in agreement with the cross-linking of polyethylenimine
with isophthalaldehyde and could form either inter- or intra-molecular cross-links. In a
relatively dilute solution, the cross-linking reaction condenses the polymer molecules
only by intra-molecular cross-linking.

I

There are growing interests in quadruplex DNA research. Quadruplex DNA is a
higher order DNA structure found in guanine rich chromosome end (telomere) regions
and in promoter regions. Interest in quadruplex DNA has advanced considerably due to
its utilization in cancer treatments. We looked for polymers which can bind to
quadruplex DNA without disrupting the quadruplex structure. The
d(T4G4) repeated sequence can fold into quadruplex structure in its telomere region and
has been found in a living organism (sty/onychia). The synthetic DNA sequence of
(TTTTGGGG)4, (32-bps), was used in this study. We have studied the interaction ofPEl
with quadruplex T4G4 DNA by circular dichroism, UV, and NMR.

It is known that the PEls (cationic polymers) were shown to interact with
.quadruplex DNA. Our CD spectroscopy results suggested that PEl might disrupt the
quadruplex DNA and converted it into a hybrid or unknown structure. However, it is
currently unclear what the structure of the quadruplex DNA was.
Our ultimate aim is to be able to find the suitable polymer for our imprinted model
in DNA researches. Porphyrins are known to successfully bind to quadruplex structures.

Toward this goal, we have used cationic tetrapyridyl porphyrin (TMPyP4) as a probe to
screen the interaction of the quadruplex DNA with different categories of polymers.
Here, we have found that the UV-Vis binding interaction of porphyrin, polymers and
quadruplex DNA have shown that the Soret bands of the porphyrins changed drastically
upon addition ofquadruplex DNA, with bathochromic shifts (to longer wavelength). By
addition of polymers into porphyrin I quadruplex complex, the Soret band was observed
to shift to different position as a function of polymer structure.

2

Our UV-Vis data have revealed that the cationic polymer (e.g. PEl) might disrupt
quadruplexes DNA or alter it to an unknown or hybrid structures; the neutral polymers
might associate with quadruplex DNA without structural disruption. However, the 31p
NMR studied showed only a weak binding or non·binding interaction for poly (4·
vinylpyridine N-oxide) and poly (N.vinylpyrrolidone) with quadruplex DNA. These
results motivate us for further investigation of the neutral polymers.

3

Dissertation Structure
This dissertation is organized in the following order: An introduction to the research
is presented in Chapter 1; an historical overview is given in Chapter 2; the theory ofthe
methodologies are given in Chapter 3; materials and experimental methods are in Chapter
4, results and discussion are given in Chapter 5; and Chapter 6 is comprised of the
conclusion and possible future work, followed by references.

4

CHAPTER 1 INTRODUCTION
1.1 Polymers as non-viral nucleic acid vehicles
Cancer has become the number one killer in developing countries and is moving
toward being the number one cause of death in industrialized countries. 1 Because of the
aggressive growth of tumor cells, and the complex mechanism in cancer developments,
standard treatments are not sufficiently effective in many cases. 2 Therefore, the search
for new anticancer strategies becomes urgently required. In this regard, a better
understanding of the relationship between growing cancer cells and genes led researchers
to search for new approaches for treatments. The growing interest in gene therapy has
become an attractive concept in recent years because it provides a promising tool for
treating the tumor cells. 34

In past decades, gene therapy has emerged as a powerful, new therapeutic
intervention for gene-related diseases and has gained increasing attention in medicine,
biotechnology and the pharmaceutical sciences. S DNA is the hereditary material in all
living organisms. An efficient gene carrier is required to be able to deliver the genetic
material into target cells. The efficiency and safety for a specific delivery of therapeutic
genes remains an important bottleneck for the development of gene therapy. To date,
developing a stable and efficient delivery system is still a major challenge. The key
considerations for the development of gene therapy strategies are to improve the
efficiency and safety of genes after their administration into the body. Gene delivery
systems are currently under investigation for both viral and non-viral carriers. 6
The limitations of viral vectors and cellular barriers (extracellular/ intracellular) are
the critical issues for gene delivery. There is a need for development of an appropriate

5

delivery system to enhance efficiency.7-9 The viral carriers can produce efficient gene
expression but have high immunogenicity issues. 10 The virus gene carrier also has
drawbacks in the size capacity of therapeutic DNA and difficulty in targeting specific cell
types. Although virus carriers are efficient gene delivery agents, a high death toll in
clinical trials has been reported over the past decades. 11·12

The attempt to achieve

successful gene therapy has led to the evaluation and development of alternative vectors.
Synthetic non-viral systems have showed an interesting pharmaceutical profile with
potential advantages for certain applications. l3 ' 18 The non-viral delivery systems have
become one of the alternative methods because of their favorable gene delivery
characteristics such as low immunogenicity, less size limitation, increased cost efficiency
and facility of modification. 19
Non-viral carriers are mainly found in three categories: naked DNA delivery, lipid
based delivery, and polymer-based delivery.2o A wide range of polymeric vectors, most
ofa cationic nature, have been utilized to deliver therapeutic genes in vivO. 2I -22 The
cationic polymers have been used as possible alternative vectors for viral and liposomal
carriers in a gene delivery system.23-24 The advantage of using cationic polymers is that
cationic polymers have many different structural elements which can self-assemble with
negatively charged nucleic acids via electrostatic interactions to condense the string-like
nucleic acids into compact nanoparticles. 25
DNA molecules are large domains which can have a wormlike random coil
structure. The DNA condensation will decrease the size of the DNA chains into compact,
orderly structures by which the genetic information is packaged and protected. DNA

6

condensation processes enable DNA easily to transfer into the target cells for gene
therapy applications. The dominant forces ofthe DNA condensation are attractive
(counterion, cross-linking) forces, hydration forces and repulsion (electrostatics) forces.
The multivalent cation condensation process can provide the free energy which can
then stabilize the condensed state of DNA molecules.

26

The electrostatic attraction

between positively charged cationic polymers and negatively charged DNA results in the
formation of the polyplex. In swnmary, the cationic polymers are known to receive the
most attention as potential non-viral gene carriers.

1.2 Polymers and Quadruplex DNA Interaction
James Watson and Francis Crick were the first to discover right-handed double
helical DNA structures.

27

After a few decades, more polymorphic natural DNA

structures have been reported. There is an increasing interest in a number of other DNA
forms and their role in biological activities. Four-stranded helical guanine-rich DNA
structures, joined by hydrogen bonds through Hoogsteen base pairing to form a planar
structure, are of particular interest among the various DNA structures. 28
The human telomere with a long 3' overhang of a G-rich strand can adopt an unusual
four-stranded structure called a G- quadruplex?9 This quadruplex DNA displays a
significant role in the regulation oftelomerase activity; due to the inhibition of the
enzyme telomerase, the G- quadruplex structures have been considered as a target design
for anticancer drugS. 30 33
Monovalent cations play an important role in the formation of the quadruplex
structures. G-quadruplex formation varies with the cation species. The binding preference
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of monovalent cations for G-quadruplex structures is K+>Na+>Cs+>Li+.

34

Potassium has

significant binding preference over other alkali metal ions due to the following reasons:
(A) Ionic radius: potassium has an ionic radius of approximately 1.3 A which fits well in
the guanine tetrads' cavities. (B) Physiological concentrations: physiological conditions
provide optimal stability for potassium ions. The potassium ion can induce the formation
ofthe G-quadruplex structure by a slow unfolding reaction. 35
The original concept of this research was designed to investigate the possibility for
applying polymers using an imprinting model. Traditionally, a polymerization in the
presence of a cross-linker is performed to prepare this architecture. This was done by
cross-linking the polymer to form a template which interacts with the nucleic acid (DNA)
and formed a complex. The imprinted template is removed from the polymer by melting
or dialysis of the DNA and leaves behind the specific binding site to serve as a "lock and
key',.36-37
Cationic polymers are well documented in many studies for binding to anionic DNA
to provide the control release of DNA polyplexes. 38-40

We examined polycationic

polymers as potential candidates because the electrostatic interactions between the
negative charge of the nucleic acid and positive charge of the polycation will attract each
other. Our interest has focused on one of the cationic polymers- polyethylenimine (pEn.
PEl has been used as a non-viral gene delivery system for many years. 41
Our experiments identified that one of the cross-linkers, isophthalaldehyde (an
aromatic dialdehyde), was able to cross-link with PEl to form nanoparticles. The
interaction between polymers and DNA has been studied by many researchers. 37-38,42
We are interested in how the polyethylenimine condensed with the quadruplex DNA, and
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any confonnational changes of the DNA induced by the interaction with the quadruplex
DNA.
Structure of Isophthalaldehyde

r0p

OHC~CHO
Cationic porphyrins have been noted for their ability to bind and to stabilize the G·
quadruplex DNA.

43

We utilized cationic porphyrins as a probe to screen the interaction

ofthe quadruplex DNA with different categories of polymers. The aim in this research is
to explore the infonnation ofthe potential polymer candidates which can be used for the
DNA binding and apply the resulting infonnation in nucleic acid research.

9
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CHAPTER 2 HISTORICAL
2.1 Polymers
Polymers are molecules that are composed of a large number of repeated units
(monomers) which are linked by covalent bonds to form macromolecules. The large
number of different building blocks ofmonomers can be constituted into a wide variety
ofmacromolecules which allows for a great diversity of macromolecules. These
structures can lead to a wide range of properties, allowing polymers to play an essential
role in everyday life.

44

The types of polymers range from synthetic plastics (thermoplastic or thermoset),
films, and elastomers to natural biopolymers. The varieties of natural biopolymers
include carbohydrates, lipids, proteins and nucleic acids which are composed of different
monomers and serve different functions. Synthetic polymers are one of the largest fields
in materials science including synthetic rubber, nylon, PVC, polystyrene, polypropylene,
etc.

45

There are three classes of organic synthetic polymers by charge; these are cationic

polymers, anionic polymers and neutral polymers. In the present study, we attempted to
investigate some of the neutral and cationic polymers for their interaction with the
G-quadruplex DNA.

2.1.1 Neutral polymers
Some neutral polymers have shown the ability to interact or bind with DNA. 46
There are many non-ionic neutral polymers including polyvinylpyrrolidone (PVP),
polyvinylpolypyrrolidone (PVPP) and poly (4-vinylpyridine-N-oxide) which are able to
interact with DNA through non-condensing mechanisms.
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Polyvinylpyrrolidone (PVP) is a water- soluble homopolymer made from the
monomer N-vinyl pyrrolidone. PVP is a non-compacting but interactive polymer which
is used in many applications such as excipients or solubilizers in the pharmaceutical
industry. The interaction between DNA and PVP is based on hydrogen bonding with the
base-pair in the DNA major groove. Unlike polycationic polymers, PVP is a noncondensing polymer which does not condense DNA into a polyplex. 47 PVP binds to
DNA through hydrogen bonding between DNA and PVP, which makes the DNAlPVP
complex have less negative charge density, shielding the charged DNA from the aqueous
environment, and becoming more hydrophobic than DNA alone. The formation of
DNAlPVP complexes may lead to improved cellular uptake of DNA and enhance the
transfection efficiency.48

Figure 2.1: Chemical Structure of the Polyvinylpyrrolidone

Poly (N-Vinylpyrrolidone)

~o
(f
Polyvinylpolypyrrolidone (PVPP), a cross-linked form ofPVP, is a water-insoluble
polymer. PVPP is considered as a non-condensing agent which can be used in
biochemical techniques such as DNA extraction.

(
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Poly (4-vinylpyridine-N- oxide) (PVPyNO), the N oxidation product of poly
(vinylpyridine), is a water soluble polymer. Poly (4-vinylpyridine-N-oxide) has a charge
separation across the N+-+O- bond with a large dipole moment which can fonn a partial
complex with water to transfonn the N-O group into a weak acid. Holt presented
evidence suggesting that poly (4-vinylpyridine-N-oxide) and other non-ionic polymers
are able to inhibit cytotoxic activity in cell cultures.

49

Figure 2.2 shows the structure of

some polymers which are covered in the study.

Figure 2.2:

Structure of Polymers in the Study

Poly (2-vinylpyridine-N-oxide)

Poly (4-vinylpyridine-N-oxide)

Poly (2-vinylpyridine)

Poly (4-vinylpyridine)
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2.1.2 Cationic Polymers
There are examples of polyanionlpolycation interactions in many biological systems.
The cationic polymers have been investigated intensively as non-viral gene delivery
systems. 50 Due to their ease of modification, ready synthesis, and robust properties,
cationic polymers have proven to be more efficient gene delivery systems than other
cationic vectors (such as cationic lipids).
Although many cationic polymers can condense DNA spontaneously, they still have
limited efficiency for in vitro and in vivo gene delivery. 51 The chemical modification of
polymers and the use of specific cell-targeting ligands may be alternative solutions for
improving transfection efficiency and gene expression. Many chemically different
cationic polymers have been investigated.22 However, most polymeric vectors have
lower gene transfer efficiency than viral carriers. To improve the efficiency, there is a
need for a better understanding of the intracellular trafficking and polymer
structure/activity relationships in order to design an optimal polymer with virus-like
qualities for gene delivery.52
Poly (4-vinyl-I-methylpyridinium bromide) (PVMP Br) is a cationic water soluble
polymer with ion-exchange properties. Polyethylene glycol (pEG), a polyether
compound, is a low-toxicity hydrophilic polymer with unique physicochemical properties
such as high water-solubility, high flexibility and large exclusion volume. PEG can be
used in many areas from industrial to medicinal and is also FDA-approved as a
component of various pharmaceutical formulations. PEG conjugates with other
(cationic) polymers have been demonstrated to have the ability to improve the
transfection efficiency. 53-54
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Poly (4-vinyl-I-methylpyridinium) bromide and PEG are among the polymers
included in this investigation.

Figure 2.3: Chemical Structure ofPoly(4-Vinyl-l-methylpyridiniumbromide) and
Polyethylene glycol (pEG)
PEG

P4VMPBr

2.1.3 Polyethylenimine (PEl)
Among the various synthetic polycationic vectors, polyethylenimines have shown
particular advantages in delivery system applications. Polyethylenimine (PEl), one of
the cationic polymers, has been investigated and widely employed for the design of non
viral gene delivery vectors by many researchers for decades. 55-57 The benefits of using
polyethylenimine (pEl) as a non-viral transfection system are due to the fact that it has
strong DNA compaction capacity with an intrinsic endosomolytic activity. 58-59
The structurally different PEls are categorized into linear or branched types with a wide
range ofmolecular masses. Different molecular weights and degrees of branching of
PEls have been synthesized and evaluated for their in vitro or in vivo use.
Branched PEl is made from an acid-catalyzed aziridine ring opening reaction.
Commercially available branched PEl with molecular masses around 25 kDa is the most
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frequently study polymers. The linear PEl polymers are made by the hydrolysis of poly
(2-ethyl-2-oxazoline). Most of the amines in linear PEl are secondary amines, only the
terminal groups are primary amines. In the recent revision by the van Harpe group, they
have updated the previous information about the ratio of the primary, secondary and
tertiary amino groups in branched PEls from the ratio of 1:2: 1 (previous information) to
closer to 1: I : I.

60

Boussif et al reported that non-protonated amino groups in PEl

provided a high buffering capacity.41 The significant buffering capacity of the PEls
makes an attractive feature for proton sponge applications.
The phenomenon known as the "proton sponge effect" is the binding of cationic
polymers to lipid groups on surface membranes, which then enter an endosome resulting
in large buffering capacity. Once these cationic nanoparticles enter into an acidifying
lysosomal compartment, the non-protonated amino groups (proton acceptor) are capable
of sequestering protons that are supplied by a proton pump enzyme in the membrane.
As protons enter the endosome, this process keeps the pump functioning and leads to the
retention of one cr ion and one water molecule per proton. This influx of water causes
the endosome to burst, releasing the delivery vectors into the cytosolic space.
PEI is considered one of the most densely charged polymers due to the primary,
secondary and tertiary amino groups, which exhibit this protonation property. Every
third or fourth nitrogen atom carries a positive charge at physiological pH conditions
therefore the nitrogens are able to buffer the relatively large number of protons in the
endocytotic vesicles and keep the acidic lysosome balanced in pH.
The buffering capacity of PEl leads to osmotic swelling and rupture of endosomes,
resulting in the release of the vector into the cytoplasm. Researchers also found that
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linear (PEI-22K) and branched (PEI-25K) resulted in similar transfection efficiencies but
a different effect with liposome complexes. 60 The transfection efficiency of PEl
depends on both buffering sponge effects and molecular weight. 61 -62 Generally~ both
branched and linear PEls are considered good candidates for non-viral vectors in vitro
and in vivo. 63 The interaction between the positively charged polymer backbone and
negatively charged DNA leads to the formation ofpolyplexes.64
The positive charges of PEl are balanced by an influx of counter ions~ which will
protect DNA from degradation, such as osmotic swelling, bursting, and release into
cytoplasm. PEls show excellent ttansfection efficiency in many types of cells. 6s With a
strong DNA condensation capacity and intrinsic endosomolytic activity, PEl is
considered one of the most effective polymer-based non-viral gene carriers over other
polycations. 66 68
Studies on the interaction between quadruplex DNA and polycationic polymers have
attracted much attention in the past decades. 69

Sun and co-workers 70 have reported that

PEl can be used with G-quadruplex ligands, which could stabilize and regulate intra
molecular G- quadruplexes and condense DNA to form a compact structure. 71  72
Figure 2.4 shows the structure of the polyethylenimine, denoting the primary,
secondary and tertiary amine sites. Figure 2.5 shows the branched PEl structure.
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Figure 2.4: General Structure of PEl with Primary, Secondary and Tertiary
Amines
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Figure 2.5: Branched Polyethylenimine
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Adopted from Kulkarni, R Petal., PNAS 2005, 102, 7523·7528

PEl can induce the formation of a G-quadruplex structure via electrostatic
interaction and condensation effect. Figure 2.6 shows the formation of G-quadruplex by
PEl condensation via negatively charged DNA and positively charged PEl through
electrostatic interaction.

Figure 2.6:

Condensation of Anionic DNA with Cationic PEl

DNA

PEl

PEIIDNA

Adopted from Sun, H. et aI, Bioorganic & Medicinal Chemistry letters. 2009, 19,4669-4672
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2.1.4 Cross-Linking

Cross-linking, one of the useful techniques for polymer structure modification, is a
process by which long chains of polymers are linked together (usually at random sites in
the middle of the chains), increasing the molecular mass and forming network polymers.
Cross-linking reactions may occur by chemical or physical processes which are possible
in natural or synthetic polymers. Physical cross-linking is a reversible reaction and
occurs on the surface of the polymers. Chemical cross-linking, an irreversible and
typically stable reaction, can be done by joining the chemically reactive groups within the
polymer structure to form cross-links with other polymer molecules.
For the chemically reactive groups, specific chemical processes are the basic
elements for the cross-linking reaction. Amine, carboxyl, sulfhydryl, aldehyde or
hydroxyl groups are some of the typical chemical reactive groups which are required for
cross-linking. Covalent bonds, ionic bonds or hydrogen-bonds can all be used in the
formation of cross-links.
The properties of the polymer can be modified by the degree of cross-linking. For
example, polymers with a higher degree of cross-linking will produce stiffer and more
rigid materials which will increase the polymer strength, improve the resistance to
chemicals, etc.

2.1.5 Cross-Linking Polymers
High molecular weight cationic polymers possess low gene transfection efficiency
and often high cytotoxicities. 73 -74

In the efforts to develop a safe and efficient polymeric

gene vector, modification of the polymeric vectors has been widely used.
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75-76

Cross
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linking, copolymerization, grafting and conjugation are common practices of the polymer
modification processes which can be applied to polymers to improve the gene delivery
c: h'19her gene translectlon
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2.1.6 Amine-Aldehyde Reaction

Isophthalaldehyde has two carbonyl groups which can react with the primary amine
(from PEl) to form cross-links. The primary amines (R-NH2 or ArNH2), can undergo
nucleophilic addition in which the carbonyls can react with primary amines to form stable
imine bonds, creating cross-linked nanoparticles. Aromatic aldehydes, such as
isophthalaldehyde, usually make stable imines with either aliphatic or aromatic amines,
unlike aliphatic aldehydes, where the imines readily hydrolyze in water.

2.1.7

Pre-Screening Polymer Candidates for Nucleic Acid Delivery System

Cationic porphyrins are known to have a high affmity for binding to quadruplex
DNA by intercalation or outside stacking to DNA. 79 In the present work; we used
porphyrins as a probe to investigate the binding interaction between DNA and polymers.
The porphyrin contains four pyrrole rings with conjugated double bonds and four methyl
pyridinium groups at the meso positions. This metal-free tetra-cationic porphyrin
structure has similar molecular dimensions as the G- tetrad; thus it has a good fit for
intercalation or stacking with the quadruplex structure. 80-81

Porphyrins are also known

to bind and stabilize different types of G-quadruplex structures and form DNA-porphyrin
complexes. 82-87

Electronic spectroscopy is used to evaluate the binding of porphyrin to

quadruplex DNA with selected polymers. Free porphyrin has a Soret band with a A.max of
422 nm; in the presence ofquadruplex DNA, the porphyrin binds and the Soret

19

absorption maximum shifts to longer wavelength (Amax =433 nm). When binding of
DNA and porphyrin is disrupted - by stronger binding between quadruplex DNA and
polymers, for example - the Soret Arnax will shift back to the free porphyrin wavelength.
This data can provide us with information on strength and mode of binding by the
polymer candidates.
Structure of Porphyrin

2.2 DNA Structure and Function
2.2.1 Nitrogen Bases, Nucleosides, and Nucleotides
Purine and pyrimidine derivatives are the nucleobases which are required for
formation of nucleosides and nucleotides. Purine is a bicyclic base which consists of a
six-membered and a five-membered nitrogen containing rings fused together, with four
nitrogens in the position of 1,3, 7, and 9. The naturally occurring purine bases are
adenine (A) and guanine (G). The monocyclic bases are pyrimidines. Thymine (T),
uracil (U), and cytosine (C) are the most common pyrimidine bases. Uracil has a
structure similar to thymine but lacks a methyl group-uracil is found in RNA, thymine is
in DNA.
Pyrimidine and purine bases have at least one N-H position which can be linked to a
sugar to form the basic building blocks for nucleic acids. In the nucleic acids and
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polymers, the adenine and guanine (purine bases) are complementary with thymine/uracil
and cytosine (pyrimidine bases) to form different structures. 88' 9O

Figure 2.7:

Major Purine and Pyrimidine Bases
Purine Base
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Nucleosides are glycosylamines consisting ofthe sugar (ribose or deoxyribose) and
nitrogenous base. The nitrogen base joins together with sugar component via a
~.glycosidic

linkage which is attached to the N-9 position of a purine base or to the N·l

position of a pyrimidine base. Nucleotides are the basic monomer building blocks
which, when joined together, make up the structural units of nucleic acids. The only
difference between the nucleosides and the nucleotides is that the nucleotide contains one
or more phosphates linked to carbon 51 ofthe sugar through a phosphate ester linkage.
The alternating sugar and phosphate groups link together in a long chain to form the
backbone of a nucleic acid. Figure 2.8 shows the formation of a polynucleotide.
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Figure 2.8: The Formation of Polynucleotide
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Adapted from www.click4biology.info: DNA Structure

2.2.2 Deoxyribonucleic Acid (DNA)
2.2.2.1 History of the DNA
Nucleic acids are polynucleotides, a polymeric compound, consisting of a number of
nucleotide monomers covalently bonded in a chain.

DNA (deoxyribonucleic acid) and

RNA (ribonucleic acid) are the most common polynucleotides. Deoxyribonucleic acid

(
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(DNA) is the unit of heredity which is associated with the transmission of genetic
information in almost all activities of cells.

In 1869, scientist Johann Friedrich Miescher was the first person who isolated DNA.
In 1919, the major components of DNA were identified by a Russian-American
biochemist, Phoebus Levene. 91 •92

The first DNA sequences were confirmed by William

Astbury, who used X-ray diffraction to disclose DNA patterns in 1937.93

The fact that

DNA carried genetic information was proved in 1952 by Alfred Hershey.94 James
Watson and Francis Crick applied Chargarrs rule to modeling the DNA structure; the
famous DNA double helix structure was proposed in 1953. 95

2.2.2.2 Base Pairing Role in Nucleic Acid Structures
Nucleic acid base pairings are very important for the formation of a variety of DNA
structures. The structure of DNA depends upon the nitrogen bases which join together
through hydrogen bonds. Nucleotide base pairing follows rules during replication,
transcription, and translation. Base pairings are important in sequence-specific
recognition for nucleic acid. Hydrogen bonding plays a role in maintaining the stability of
the molecular structure. The base-pairing rules govern the appropriate geometry
relationships for hydrogen bonding which allow only the correct pairs to form in a stable
structure. For example: DNA structures with high GC content are more stable than
structures with less GC content. Adenine and guanine (the purine bicyclic molecules)
pairs are energetically unfavorable since the larger rings are too close to each other which
lead to molecular overlapping and repUlsion. The cytosine and thymine (also uracil) have
a single-ring (pyrimidine) small molecular structure. Cytosine and thymine pairs or
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pairing with uracil are also an energetically unfavorable due to the two bases being too
far apart. The only favorable pairings are the GC pairings or AT (AU) pairings which are
energetically favorable for a stable molecular structure.
The G'C pairing and A-T pairing are usually arranged in "Watson-Crick" base
pairing where maximally three hydrogen bonds are formed between G'C pair and two
hydrogen bonds are formed between A'T pair. (Figure 2.9) These conformations are
involved in the cis hydrogen bonding pattern and is symmetrical to the C l'---C I ' vector
of the two bases.

96

Some other alternate hydrogen bonding patterns between base pairs can also occur
in the nucleic acids, such as the wobble base pair and Hoogsteen base pair. Base pairing
is a mechanism which can provide messages for molecular recognition. The Hoogsteen
base-pairing model is different from the Watson and Crick model. using the N7 atom of
the purine instead of the Nt atom to form the hydrogen bonding. Figure 2.10 show the
difference between Watson-Crick and Hoogsteen base pairing models.

{
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Figure 2.9: Watson-Crick Base Pairing- A: T and G: C fonned by hydrogen
bonding A-T base pairing fonn two hydrogen bonds and G-C base
pairing fonns three hydrogen bonds.

A:T Base Palmg

G:C Base PairiDg
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Figure 2.10: Difference between Watson -Crick and Hoogsteen Base Pairing
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Adapted from Mathews, C.K.; Van Holde, K.E., Biochemistry 2/e. 1990,The Benjamin/Cummings
Publishing Co., Inc.

2.2.2.3 Tautomerization of DNA Bases
The four DNA bases are all polyfunctional bases, and may exist in tautomeric fonns.
Tautomers are isomers of organic compounds that interconvert by a chemical reaction
(tautomerization) usually migration of a proton and the shifting of bonding electrons.
Tautomerism, the equilibrium between two such different structures, can play an
important role in non-canonical base pairing in nucleic acids and might have biological
significance. In DNA, the nucleotide bases nonnally are in the keto fonn. However, the
keto and enol fonns exist in dynamic equilibrium. Adenine and cytosine are cyclic
amidines which exist in either amino or imino fonns. Guanine and thymine can have
alternate molecular structures based on different locations of a particular proton. The
cyclic amide structures of guanine and thymine can exist in either lactam (keto) or lactim
(enol) tautomeric fonns. The keto fonn occurs when the proton bonds to a nitrogen atom
27
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in the ring. An enol fonn occurs when the proton bonds to the exocyclic oxygen. Both
guanine and thymine can switch easily between tautomers. The tautomeric fonns change
shape which can affect the three-dimensional structure of the molecule.

The tautomeric

fonns exist in equilibrium but the amino and lactam tautomers are more stable and
therefore predominate inside most cells under physiological conditions. 97 Figure 2.11
shows the tautomers ofnucleobases (A, C, G, T) in imino or lactim fonn.

(
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Figure 2.11:

Tautomers of Nucleobases
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2.2.3 DNA Structure
DNA is a highly polymorphic molecule. The structures of DNA have a variety of
conformation and structural motifs, including primary, secondary, tertiary and other
higher order structures. The terms primary, secondary, tertiary, and quaternary structure
were first defined in 1951 by Kaj Ulrik Linderstrem-Lang, a Danish protein scientist.

98

Primary structure is the raw sequence ofnucleotide bases in each ofthe complementary
DNA strands. The secondary structure is how the strands ofDNA are arranged. This can
involve two or more strands, hydrogen-bonding in a highly specific way determined by
the primary structure. Most ofthe DNA in cells occurs in double helix structures.
However, other arrangements are also possible in the genome. The double helix DNA
under certain conditions can accommodate a third strand in its major groove to form a
triple helix structure (such as Hoogsteen triplexes). The three-stranded helical DNA has
been observed and studied by some researchers. 99 In addition to three-stranded DNA,
the four-stranded tetraplex structures also have been shown to exist; they have been
found in some of the multiple folded protein or coiling protein molecules in a multi
subunit complex or in higher order DNA structures. Quadruplex DNA has been found in
a variety of organisms particularly in telomeric repeats units.

(
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Figure 2.12: Typical Double Strand Formation- The two strands are anti-parallel (one
strand is 5' to 3' direction, the other strand is 3' to 5' in opposite direction).

Adapted from Horton, R.A., Principles ofBiochemistry, 4/e, 2006 Pearson Prentice Hall, Inc.

2.2.3.1 Alternative DNA Conformation
DNA is usually a double helix with the two strands running in opposite directions.
DNA can adopt other secondary structures which form various possible conformations
and shapes. Each structural conformation is found to be dependent on the specific base
sequence patterns in which each plays its different biological role. lOO Under different
applied forces such as twists or hydration conditions, DNA duplex can adopt many
helical conformations that include the well- known A- DNA, B- DNA and Z-DNA,
although this does not cover all conformations. Only B-DNA and Z-DNA have been
directly observed in functional organisms. Z -DNA has been difficult to study because it
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does not exist as a stable feature of the double helix structures. Instead, it is a transient
structure that is occasionally induced by biological activity and then quickly
disappears. IO ! Z-DNA occurs in a dynamic state, forming transitions between left
handed Z-DNA (during the physiological processes) and right-handed B-DNA (relaxing
state) with the formation of the BZ-junctions. 102
BFormDNA
The most common DNA double helix structure in solution is known as B-DNA. B
form DNA is a right-hand double helix structure which usually occurs in a high humidity
and low salt condition. In this structure, two single strands are antiparallel and
intertwined together to form a helix. The B-DNA structures are very similar to Watson
and Crick's modeL However, there are still numerous variations in the structure and the
individual base pairs. Many bases are not exactly planar but are slightly twisted
(propeller twist) in B-DNA.

Figure 2.13: B-DNA Base Angle Orientation

B·DNA Base Orientation· Propeller Twist

Adapted from www.biochem.arizona.edu
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B-fonn DNA has all its bases in the anti-confonnation; the intertwined strands are
organized with the bases which create two grooves in different size: a major (wider)
groove and a minor (narrow) groove. The wider major groove is easily accessed by
proteins. The stability of the B-DNA double helix is detennined by hydrophobic base
stacking interactions (van der Waals forces) between adjacent base pairs and hydrogen
bonds fonning between the base-pairs and grooves.I03-104

A FonnDNA
A-DNA occurs only in a dehydrated condition and usually is observed in RNA and
RNA-DNA duplexes. When B- DNA undergoes an applied force such as a high salt or
alcohol solutions, the DNA structure may change to A- DNA. A-DNA is a right-handed
compact structure; its helix is shorter and wider than B-DNA.

A-DNA has a deep and

narrow major groove so it is not easily accessible to proteins. However, the wide and
shallow minor groove allows proteins to stack inside. Ios

Z Fonn DNA
It was not unti11970s, that the first single- crystal x-ray revealed the structures of
the left-handed double helix DNA fragment. The alternating pyrimidine-purine
sequences (especially poly (dGh) in alcohol or high salt solutions tend to have Z fonn
structure. Transition from the right-handed B fonn to the left-handed Z fonn is due to the
upside-down flip of the base pairs through a rotation of every other purine from the anti
to the syn confonnation. The two anti-parallel chains wind to the left which causes the
backbone to fonn a zigzag pattern by Watson-Crick base pairs. 106 Z-DNA has a
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narrower, more elongated helix than A form or B form DNA.

Z-DNA can form a

junction with B-DNA in a structure which involves the extrusion of a base pair. \07

Z-DNA is a higher energy form of the double helix structure which is stabilized by
negative supercoiling. 108
It has been proposed that A- form DNA (low humidity) is considered to be more
hydrophobic and results in the different packing modes of DNA. 109-1 10 Table 1 is the list
of comparison of the A, B, Z forms of DNA.

Table 1: A-Form, B-Form and Z-Form Geometry Comparison

Geometry
Attribute

A-form

B-form

Z-form

Helix sense
Repeating unit
Rotationlbp
Mean bp/turn
Inclination of bp
to axis
Rise/bp along axis

right-handed
I bp
33.6°
11
+19°

right-handed
1 bp
35.9°
10.5
-1.2°

left-handed
2bp
60°/2
12
-9°

2.4 A (0.24 urn)

3.7 A (0.37 urn)

Rise/turn of helix

24.6 A (2.46 urn)

3.4 A {0.34
urn)
33.2 A {3.32

i

45.6 A (4.56 urn)

nm)
Mean propeller
twist
Glycosyl angle

+18°

+16°

0°

anti

anti

Sugar pucker

C3'-endo

C2'-endo

pyrimidine: anti,
purine: svn
C: C2'-endo,
G: C2'-exo

Adapted from reference 109-110
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Figure 2.14: Band Z Form DNA Double Helix Conformations
The major difference between B-DNA and Z-DNA is that B-DNA possesses
a minor and major groove. Z- DNA only has minor grooves

Band Z Form DNA

Adapted from: http://bioinf.mpi-inf.mpg.de

Triplex DNA
Three stranded helical DNA structures have been observed and have been studied
intensively by some researchers. The formation of the triplex DNA occurs when
pyrimidine or purine bases occupy the major groove of the DNA double helix forming
Hoogsteen pairs with purines of the Watson-Crick base pairs.

The purine bases of DNA

have hydrogen bonding donors and acceptors that are able to form two additional
hydrogen bonds (Hoogsteen base pairs) in the major groove.
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As a pre-requisite, the DNA duplexes must contain only purine bases in one strand
and only pyrimidines in the complementary strand. These duplexes are capable of
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forming a triplex with a third pyrimidine strand in a homopyrimidine/homopurine region
of DNA. Thus, the triple-helical DNAs using Hoogsteen pairings consist of two homopyrimidines and one homo-purine and the homo-pyrimidine third strand is parallel to the
homo- purine strand. Triple helices consisting of one pyrimidine (T, C) and two purine
(A, G) strands were also proposed. For example: A *AT or G*GC. ll2 113

Figure 2.15: Triplex DNA
A third strand of DNA can fit in the major groove of duplex DNA to form triplex DNA.
Duplex DNA (grey) interacts with the third DNA strand to form a triplex (blue).

a)

b) Example of the Chemical Structure of triplex DNA

C.-GC

T-AT

Adapted from www.atdbio.com!contentJ13/oligonuleotides-as-drug
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2.3

DNA, Telomeres and Telomerase

2.3.1 Mechanism of Gene Delivery System
Since the mid-l 960s there has been interest in using gene therapy applied to the
possible treatment of genetic disorders. In 1990, the first phase I gene therapy clinical
trial was reported with promising results. I 14

Genes, the basic units of heredity, have

specific sequences of bases that encode instructions for the production of proteins.
When gene sequences are altered, the encoded proteins are not able to perform their
normal functions, which create genetic disorders. Gene therapy is a technique which has
the potential to correct the defective genes and treat the genetic disorder disease.
From the years 1989 to 1994, many gene-based therapy protocols were approved
worldwide for treatment of the inherited genetic disorders. I IS There are many different
methods of gene delivery which have been developed for a variety of cell types and
tissues, ranging from bacterial to mammalian.116-117

Gene carriers need to overcome

many obstacles of both intra and extracellular barriers to reach the target site. The intra
and extracellular barriers include crossing the plasma membranes, escape from
endocytosis vesicles, migration to the nucleus, then release of the genetic information at
the appropriate location.
Typically gene delivery methods can be divided into viral and non-viral systems.
A virus is capable of transferring its genetic materials into host cells. Although viral
vectors are highly efficient in gene delivery, there are still problems with safety and other
limitations. The disadvantages have encouraged researchers to focus on alternative
systems - non viral methods. 118-119 Non-viral synthetic vectors are able to interact with
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negatively charged DNA through electrostatic interactions and condense DNA particles;
therefore allowing transfer of the genetic materials into target cells. 120-121
Figure 2.16 illustrates the formation of the polyplex and cellular uptake via an endocytic
pathway in the following steps.
Step one: DNA is condensed with a mixture of polycations-ligand (for receptormediated uptake) to form a polyplex. Step two: Receptor-mediated uptake of the
polyplex into the endosomal vesicles. Step three: Acid-triggered deshielding and
exposure of the positive inner polyplex core. 122

Figure 2.16: Cellular Uptake via an Endocytic Pathway
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2.3.2 DNA Replication
In all living organisms. DNA replication is the basic process for passing down

biological inheritance. Before cell division. a copy of DNA must be made for the
daughter cells. This process is called DNA replication.
The replication begins with the "unzipping" of the parent molecule and uses the
original double-stranded DNA molecule as a template for the reproduction of the
complementary strand. Hence, following DNA replication. two identical double stranded
DNA daughter molecules have been produced from each original double-stranded DNA
molecule. Figure 2.17 gives the explicit structure of the DNA replication fork.

Figure 2.17: DNA Replication Fork

Jmagine adapted from http://notesforparkistan.blogspot.com

When completing the replication processes; two DNA molecules are formed
identical to each other and identical to the parent strand. DNA polymerase and other
proteins work together to initiate the elongation of DNA. 123-124 These two strands serve
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as the templates in which one is called the leading strand and the other is called the
lagging strand. The DNA polymerase can read the template and continuously adds
complementary nucleotides to the template. The leading strand template is oriented in a
3' to 5' direction. The lagging strand is oriented 5' to 3' but will create DNA fragments in
the 3' to 5' direction.

DNA has a ladder-like structure with hydrogen bonds holding two

DNA strands together. When the hydrogen bonds are broken, the resulting structure can
form a fork shape which is made up from two single strands DNA. The replication fork is
a structure that forms within the nucleus during DNA replication. 125
A problem that occurs during the replication process is that on one strand the
replication process creates discontinuous fragments of daughter strand DNA. This is
because, DNA synthesis can only occur in one direction (5' to 3'). The original DNA
strand must be read from 3' to 5' to produce a 5' to 3' nascent strand. One of the daughter
DNA molecules must synthesize in a discontinuous manner. The resulting
polynucleotide segments (called Okazaki fragments) are then stitched together into the
lagging strand by DNA ligase I.
Figure 2.18 illustrates the process of the DNA replication. 126•127 Step 1 is the
unwinding process. Step 2 is preparation for replication. Step 3 is elongation of the 5'-3'
template and the 3'-5' template. Step 4 is a connection step (join DNA fragments). In the
lagging strand the DNA polymerase I (exonuclease) reads the fragments and removes the
RNA primers. The gaps are closed with the action of the DNA polymerase and DNA
ligase.
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Figure 2.18: The Steps of the DNA Replication
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2.3.3 Telomeres and Telomerase
In 1938 Hermann J. Muller, a remarkable scientist, was the first to discover and

name the telomeres. Muller found that telomeres served as protective caps that could
protect DNA from damage when the DNA replication cycle took place.
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In the past

few decades, telomeres have gained attention for many researchers because of many
interesting topics relating to cellular aging and cancer. Telomeres have been shown to
form a variety of G-quadruplex structures. 129 G-quadruplex structures are now being
considered as targets for drug design.130
Telomeres are structures located at the ends of the chromosomes which protect
chromosomal DNA from degradation and recombination, and is part of the complex
cascade oforganism aging. 131 •133 The chromosomes are a long strand of coiled DNA,
located inside the nucleus. The structure of the telomere consists of simple tandem repeat
DNA sequences, Human telomeres have the sequence (TTAGGG)n. 134•135 These
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repeating sequences make up a portion of the double-strand telomeric DNA with a piece
of single-strand tail overhanging the G-rich 3' end DNA which contributes to the
secondary structure of the telomere. The human overhanging sequence consists of 100
200 telomeric repeating units which could form G-quadruplex structures. 136.137
The chromosomes shorten at the ends in every cycle of cell division, eventually
impacting needed genetic material. Telomeres play an important role in preventing the
degradation of the chromosomes. 138.140 The known biological function of telomeres is
to protect the chromosome ends from fusion, degradation and to maintain the integrity of
the genetic material in the chromosomes. 141·143
In 1940, Barbara McClintock discovered the behavior of the ruptured chromosomes

which resulted in fusion and adhesion of the end of the chromosome. Barbara
McClintock demonstrated that the telomere had the ability to repair the damage to the end
of the chromosomes.l44oI45 In 1973 Alexey Olovnikov, a Soviet biologist, hypothesized
that the telomere is critical in the understanding of aging and cancer. 146 It was not until
1978 that Elizabeth Blackburn and Joseph Gall discovered that a reverse transcriptase

enzyme, telomerase, plays a key role in normal cell functions as well as in cell aging or
cancers. Elizabeth Blackburn. Carol Greider and Jack Szostak were awarded the Nobel
Prize in 2009 for resolving the end replication problem. 147 Telomerase has the ability to
elongate the G- rich strand oftelomeric DNA. Thus telomeres and telomerase may be
proposed as attractive targets for the discovery ofnew anticancer drugs. 148
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2.3.4 Telomerase and Aging
There is increasing evidence to indicate that telomerase plays an important role
during the replication of mammalian telomeres. 149 During a life span, cells divide over
and over to keep the body alive, but the telomeres grow shorter with each division. To
address the consequences of incomplete replication, nearly all eukaryote cells have the
ability to employ a telomere at the ends of chromosome. In the absence of a special
telomere maintenance mechanism, telomeres wi1l10se or damage some essential parts of
DNA sequences during the cell replication cycles; which is due to the inability of DNA
polymerase to fully replicate the chromosome ends. The length ofthe telomeres over time
is connected to cell aging and lifespan.

In 1987, Blackburn and her coworkers made the astounding discovery that
telomerase (a ribonucleoprotein reverse transcriptase) activity might be able to extend
telomeric sequences. ISO Telomerase can synthesize telomeric repeats units and add them
onto the ends of chromosomes. A variety of premature aging syndromes are associated
with short telomeres.

lsl

However, the premature aging can be reversed by telomerase

enzyme that can prevent the shortening at the of chromosomes.1 52 In 2000, Geron
Corporation revealed a study results that addressed the telomerase-based therapies could
not only prevent but also reverse the aging process in humans. IS3

2.3.5 Telomerase and Cancer
Telomerase enzymes were found active in most human tumor cells and the
telomerase activity is found to be involved in about 85% to 90% of human cancers.154.IS6
Cancer is a condition in which certain cells in the body are growing and dividing
uncontrollably. Most cancers are the result of "immortal" cells which have ways of
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evading this programmed destruction. IS7 Normally telomeres shorten significantly and
will lead to cell death or sustain damage that can cause cancer,lSS Every living system
should maintain a balance of the cells replicating and dying. If there are too many of the
same types of cell gathering together this wi111ead to cell abnormality or cancer,IS9-162 In
about 90% ofcancer cells telomerases have been found,163.166

For this reason, many

researchers believe that part of forming an abnormal cell in cancer is the activation of
telomerases. These cells use telomerase to overcome the incomplete end-replication
problems. Te10merase will extend the leading strand of DNA to elongate the telomere.
Telomerase inhibition has been identified as a new approach to cancer therapy. I 67·174
Dr. Michael Fossel has suggested that telomerase therapy may be used not only to
combat cancer but also to have an anti-aging effect and extend the lifespan significantly
in the human body. 175 This assumption has inspired a number of potential therapeutic
strategies. The inhibition of telomerase has become an attractive strategy for anticancer
therapy since the first demonstration of telomerase inhibition by a G-quadruplex
interactive compound in 1997. 176 The formation ofG- quadruplex complexes by
telomeric DNA has become a new direction cancer therapeutics. l77• l78

2.3.6

Quadruplex DNA

G-quadruplex structures are a class of DNA structures that may be useful in
targeting telomeres. Quadruplexes are four stranded higher order nucleic acid structures.
That guanine-rich oligonucleotides can form a quartet structure was recognized more
than forty years ago. Gellert et al. proposed that guanine base sequences could form a
quartet structure through hydrogen bonding. 179 A G-quartet is formed by four guanine

!
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bases in a square planar arrangement which provides a central cavity where each guanine
acts as both donor and acceptor for hydrogen bonds. The oxygen lone pair of the carbonyl
groups within the G-quartet can associate with the metal cation in the cavity site. G
quartets can arise between G-rich strands (intermolecular) or within G-rich nucleic acid
sequences (intramolecular).
The level of interest in the G-rich structures have increased markedly in the past
decade due to the fact that guanine-rich single-stranded overhang structures can be folded
into quadruplex structures under certain physiological conditions. 180 These guanine-rich
quadruplex structures were found in G-rich eukaryotic telomere ends as well as in non
telomere genomic regions including gene promoter regions, 18I immunoglobulin switch
region, 182 and sequences associated with disease. IS3

There are studies on some naturally

occurring eukaryotic telomere repeat DNA sequences which all contain a 3' single strand
overhang to form quadruplex structures such as d(ITAGGG)n (found in vertebrate
chromosome including Homo sapiens), 184 d( ITITGGGG)n (from Stylonychia),
d(ITTAGGG)n (from Arabidopsis), and d(TGGGGT)n (from Tetrahymena)
G-quadruplex DNA displays an amazing structural polymorphism, and different
typologies of G-quadruplex may be associated with different cellular processes. The
polymorphism of the G-quadruplex structure may provide insight for achieving
therapeutic selectivity for drug design. ISS
2.3.7 Quadruplex Structure
G-rich four-stranded structures can form in different ways, by folding and base
pairing ofone, two, three, or four DNA strands. In particular, the number of structures
involving guanine tetrads has been an area of increasing interest in the past few decades.
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It is well known that DNA oligomers containing repeating guanine bases can form

specific motifs. The fundamental structural units of the quadruplex consist of a planar
arrangement of four guanines connected by hydrogen bonds for each side (tetrad), with a
central channel formed by stacking of guanine tetrads that can accommodate selectively
certain cations. 186

These planar G-quartets will stack on each other to form a higher-

order DNA structure, which is called a G_quadruplex.187-188 Figure 2.19 illustrates the
forming of the G-tetrads and G-quadruplex structures.

Figure 2.19: G-tetrads and G-quadruplex Structure.

Structure of tetrad shows hydrogen bonds between four guanines and the
a cation (M) located in the center.
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G-quadruplex

G-tetrad

Numerous studies have been shown that G-quadruplex structures are biologically
important in both in vivo and in vitro systems. 189-1 90

The structural polymorphism of

G-quadruplex DNA has been proven to affect the cellular functions. 191 The biological
relevance of the G-quadruplex may be involved in many areas: regulation of telomerase
activity, controlling biological phenomena, functional molecules, and nano-materials.
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The polymorphic nature of the G-quadruplex structure might also explore the promising
future for using as a building block ofthe novel nanomaterials. 192

2.3.8 G-Quadruplex Architectures
G-quadruplex structures have a rich structural diversity which can align through
mismatch, triple, triad, tetrad ~d hexad alignments, resulting in unique DNA
architectures, that differ in the number and orientation of strands and pairing
alignments. 193 The organization ofthe chain direction gives rise to a large number of
possible topologies. The possible structural folding topologies of the quadruplex have
multiple conformations which can be described as parallel, antiparallel or mixtures of
these two forms. The Viglasky group has reported how protruding nucleotides can
destabilize the G-quadruplex structure, and the overhanging sequences can influence the
folding of the quadruplex.136
The topologies of different G-quadruplexes are affected by the orientation ofthe Gquartet core, the synlanti conformation of guanine residues, the association of metal
cations, and the types of linking 100ps.I94-2oo

The possible orientation of the G

quadruplex architectures may exist as unimolecular, bimolecular or tetramolecular
structures which connect their backbones with a variety ofloop types to build different
conformations of the G-quadruplexes. 201

In recent review articles of G-quadruplex

structures, 26 possible topologies have been reported. 202

However, only a few

topologies have been proven to exist in vitro 203, and there is even less knowledge of in
vivo architectures.

I
f
47

The G- quadruplex structure appears to be stabilized by a hydrogen-bonding
network which comprises a stack of two or more G-quartets linked by the phosphodiester
backbone and stabilized by a specific monovalent ion. The structural diversity and
stability of G-quadruplex structures depend on many factors: strand stoichiometry,
connecting loops, strand polarity, glycosidic torsion angle, and coordinated cations.

Strand stoichiometry: Strand stoichiometry allows G-quadruplexes to be formed from
one, two, three or four strands from unimolecular to quadrimolecular structures.

204-206

Figure 2.20: Examples of Various Strand Stoichiometries of
G-Quadruplex Structures
(A) One-stranded: a unimolecular G-quadruplex.
(B) Two strands: a bimolecular G-quadruplex.
(C) Four separate strands: a quadrimolecular G-quadruplex.
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Loop connectivity: A loop can connect guanines in a variety ways to form
unimolecular or bimolecular G- quadruplexes. 207 Figures 2.21 and 2.22 show
examples of loop connectivity of guanine tetrads.
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Figure 2.21: Unimolecular: Different way of Strand Loop Connectivity for
Guanine Tetrad Structure (A, B, C)

c

B

A

Figure 2.22: Bimolecular: Strand Loop Connectivity to form Various Guanines
Tetrad Structures (A, B, C, D, E).
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Strand Polarity: Strand polarity can induce the various sequences and different
structures arrangement in G-quadruplex. For example: all parallel, mixed parallel and
antiparallel, adjacent parallel or alternating antiparallel.208-21I
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Figure 2.23:

Strand Polarity Arrangements in G-Quadruplex Structures:
(A) all parallel, (B) three parallel and one antiparallel, (C) adjacent
parallel and (D) alternating antiparallel. Arrows indicate 5' to 3'
polarity

A
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Torsion Angle: The glycosidic torsion angle is the key factor to determine the G
quadruplex structure's orientation for paraUel or anti-parallel strands. The glycosidic
conformation changes the relative orientations of the bases in contiguous guanine tetrads
and affects the stacking energy. Parallel strands have the same glycosidic torsion angle.
Antiparallel strands have the opposite glycosidic torsion angle. Rotation around the
glycosidic bond enables the guanine base to interconvert between the syn and anti
conformations. The stacking of the guanine tetrads for parallel and antiparallel
conformations will produce different spaces in the grooves. A parallel strand will create
four medium sized grooves; an antiparallel strand will create three types of grooves:
wide, medium and narrow grooves.212-215
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Figure 2.24: Example of the syn/anti conformation structure by the rotation
of the glycosidic bond

The bond rotation can convert syn into anti or reverse conformations.
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The presence of cations is an essential element for the formation of G- quartets. The
nature of the cation can induce the conformational changes (parallel or anti-parallel) in
G-quadruplex structure. For example, the potassium ion (K) will often induce a parallel
structure. 216 Venczel and Sen reported that divalent cations (Mg2+, Ba2) are also
present in a parallel G-quadruplex structure. The sodium ion (Na) usually induces an
anti-parallel conformation. The calcium ion (Ca2) can induce a structural transition ofG
quadruplex from the antiparallel to parallel conformation.217
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Figure 2.25: Depiction of the G-Quadruplex DNA Structures: Example of the
Parallel and Anti-Parallel
Parallel Structure
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Groove Effect: Groove dimension is controlled by the glycosidic torsion angles (syn

lanti) and strand polarities. The space between the glycosidic torsion angles and strand
polarity of the quadruplex can be classified as wide (w), medium (m) or narrow (n) size
of the grooves. J99 Figure 2.26 and 2.27 show the examples of the groove effect.

Figure 2.26: Two pairs of adjacent Parallel Strands·create two
Medium Grooves

Medium

Figure 2.27: The alternating Anti·Parallel Strands: generate two
Medium and two Narrow Grooves

Wide

G-quadruplex DNA displays an amazing structural polymorphism; different
topologies of G-quadruplex may be associated with different cellular functions.
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Therefore, the polymorphism ofthe G-quadruplex can provide insight for achieving
therapeutic selectivity for drug design. As shown in Figure 2.28 and 2.29, the overall
topologies available to G-quadruplex structures depend on the combination of
antiparalleVparallel orientation of guanine tracks and arrangement of the loop.

Figure 2.28: Structures of G-Quadruplexes. Schematic representation of G
quadruplex structure: (a) G-quadruplex with three stacked quartets, (b) A
tetramolecular parallel G-quadruplex and antiparallel (c) intermolecular antiparallel G
quadruplexes (d) intramolecular fold over G-quadruplex.
(a) G-quadruplex, linked bytbe DNA backbone

(b) Parallel and Antiparallel quadruplex

ParaDe.

Tbree stacked qartets

ADtlpa raUel

G~.adra:pleJ:

(c)

(d)

Intermolecular antiparaUel
G-quadruplex
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Intramolecular foldover
G-quadruplex

Figure 2.29: Examples of inter-and intramolecular quadruplex DNA conformation
(a) Tetramolecular parallel. (b) Bimolecular antiparallel. (c) Unimolecular antiparallel.
(d) Unimolecular antiparallel. (e) Unimolecular parallel. Many sequences can also form
mixed structures or are polymorphic

Tetramolecular parallel

Bimolecular antiparallel

a

b

Unimolecular antiparallel

Unimolecular antiparallel

d

Unimolecular parallel

e

Adapted from Huppert, IL., Phil. Trans. R. Soc. A, 2007,365, 2969-2984
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2.3.9 The Stability of Quadruplex Structures
The quadruplex DNA structures are considered as compact and resistant to DNAses,
preventing the cleavage ofphosphodiester linkages in the DNA backbone. The
quadruplex structures are more stable than duplex DNA due to the presence of more
hydrogen bonding between the guanine bases. Quadruplex DNA has higher melting
temperatures than duplex DNA, which could also be due to the presence of the G-quartet
stacks stacking. 199 There have been a large number ofpublications on structure and
other properties of the quadruplex structures since the late 1980s.202.203

However, there

is still insufficient understanding of their basic physical properties.
The stability of the quadruplex structures are determined by the following factors:
the base stacking, hydrogen bonding, van der Waals forces, electrostatic interactions, the
nucleotide sequence, ionic strength, cations and temperature. Hydrogen bonding is one
of the important factors which can control the formation of both secondary and tertiary
structures. The hydrogen bonds, van der Waals forces, ionic interactions, and
hydrophobic interactions are intermolecular or intramolecular attractions which can
influence the nature of the biological structure.
The structure and stability of intramolecular quadruplexes are profoundly influenced
by the length and composition ofthe 100pS.218

Increasing the loop length will increase

the binding affinity of the quadruplex DNA. The loop length will influence the
quadruplex conformation; short loops favor parallel conformations. With increasing loop
length, quadruplex conformations prefer intra-molecular and anti-parallel
conformation. 219
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The ion-binding site is a cavity between two G-quartets that is lined with eight

0-6 atoms from guanines participating in the coordination of cations. The negatively
charged cavities located between the G-tetrads can be stabilized by the coordination of
cations (monovalent or divalent) present in the center of the cavity. With the presence of
the monovalent or divalent cations in the center, the size of the ion will affect the
interaction with the G_quartet. 220 In general, the ionic radius is a parameter that decides
how well guanine tetrads are stabilized by various cations.
Kang and coworkers, using X-ray, studied the d (G4T4G4) and reported that
pocket stacking stabilized the quadruplex structure by forming the stacking in the
adjacent G-quartet. 221 The switching between various conformations can be induced by
the presence of different cations and difference in temperature. Miyoshi's group had
found that, in low concentration, divalent cations can destabilize the anti parallel G
quartet of d(G4T4G4) structure in the following order Zn2+>C02+>Mn2+>Mi+>Ca2+. 222
Particularly, higher concentrations of divalent cations can induce structural transition
from antiparallel to parallel structure. 223 Chen reported that divalent cation induced
quadruplex structural change such as self-assembly (Mg+2) and formation of quadruplex
(Sr+2).224-225

Monovalent as well as divalent cations are an integral part ofG

quadruplex structure, and without these cations, G-quadruplexes are unstable. 226

2 .3.10 The Biological Role of the G-quadruplex DNA
Rising interest in G-quadruplex structures has been evident in the large number of
publications, books and articles. The biological functions of quadruplex DNA were a
relatively unexplored area for decades. In the last few years, the biological significance
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of these G-quadruplex structures has been explored. Evidence has been found that
quadruplex structures may be involved in many different biological phenomena.

227

G-quadruplex DNA has been studied in vitro and in vivo for some biological species.
The studies have indicated that G-quadruplex DNA might play important roles in cellular
functions such as control of gene expression,228 regulation of gene transcription, and
genomic stability.229-234
The unusual conformation of G- rich quadruplex-forming sequences have led to
. . WIt
. h cancers, ce11 agmg
. processes 235-238 and a Iso
conSI'derabl'
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participation in gene regulation and telomere maintenance.239-245 The G- quadruplex
structures were described as playing a role in the inhibition oftelomerase activity by
negatively regulating through the G-quadruplex, influencing multiple cellular processes
(transcription, translation, and replication).246-247
G-quadruplexes have been considered as a potential therapeutic target for human
cancer because they can inhibit telomerase activity, and some quadruplex-interacting
drugs can induce senescence and apoptosis of cancer cells. 248 Therefore, the use of
specifically designed G- rich sequences has motivated scientists to develop new classes
of anticancer therapeutics, therapeutic interventions and as potential targets for the design
and development of novel anticancer drugS.249-253

2.3.11 Porphyrin Chemistry
5,10, 15,20-tetra-(N-methyl-4-pyridyl)porphyrin (TMPyP4). a heterocyclic aromatic
conjugated compound, is composed of four pyrrole subunits. These pyrrole rings with
conjugated double bonds are connected so that electrons are delocalized over the
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macrocyc1e, which induces intense absorption bands in the visible region. The
stabilization of quadruplex DNA by TMPyP4 is in part due to x-x stacking interaction
between the porphyrin ring and the guanine-tetrad. A porphyrin with no metal ion in the
central cavity is called a free base. There has been considerable interest in the synthesis
of porphyrins with various substitution patterns in their ability related to the biological
functions.37 Cationic porphyrins have been known to interact with DNA and form
DNA-porphyrin complexes. The interactions between porphyrins and their derivatives
with DNA have been widely studied for potential applications in biological and medicine
sciences.254-259 It has been reported that the cationic porphyrins can interact with native
DNA and nuc1eotides through various binding modes including intercalation,260-262
external binding,263-27J random binding,272-274 and self_stacking.275-279
It has been proposed that the mode of binding to the quadruplex DNA is "face on",

including the end stacking to G-tetrad or nearby diagonal loop. In the external stacking
mode, the cationic side arms of the porphyrins probably stabilize the quadruplex structure
by reducing the electrostatic repUlsion between the anionic phosphates of the backbone of
the lateral or loops. In the external groove binding mode, the antiparallel quadruplex
DNA structure, it has been found that the porphyrin binding might be located in the
narrow or wide groove by outside stacking.180 The cationic porphyrin and derivatives
(TMPyP2, TMPyP3, and TMPyP4) have been reported to be G-quadruplex-interactive
agents that demonstrated selective binding behavior with different G-quadruplex
conformations.281
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The UV-Vis absorption spectra ofTMPyP4 have shown to be responsive to the
quadruplex stabilization. 282 However, it has been reported that this occurs through
external stacking rather than intercalating with G-quadruplex structures.
TMPyP4 is a potent inhibitor of human telomerase. The interaction ofthe cationic
porphyrin derivative with G-quadruplex DNA has the ability to inhibit telomerase due to
stabilization of the telomere.283-284 In addition, porphyrins can be used as photo
chemotherapy agents to treat cancer since they remain longer in cancer cells than in
normal cells after injection.285-286 Porphyrins linked to oligonucleotides produce various
types ofphoto-damage to the target site of DNA. Figure 2.30 shows the chemical
structure of the porphyrin and its derivates.

Figure 2.30: The Chemical Structure Porphyrin and derivates
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CHAPTER 3 INSTRUMENTATIONS
3.1 Spectroscopy
Spectroscopy is the study of the absorption and emission of light with matter. The
interaction between the matter and radiated energy depends on the process and is a
function of wavelength. Light has particle-like or wave-like characteristics which can
serve as the reference of electromagnetic radiation. The given frequency or wavelength
oflight is associated with an energy (photon). Frequency (u) and energy changes are
proportional to one another, but wavelength (A) as an inverse relationship to these
quantities (u = ciA). Different regions of the electromagnetic spectrum provide different
kinds of information about the structure of the atoms or molecules. The electromagnetic
spectrum ranges from very short wavelengths (including gamma and x-rays) to very long
wavelengths (including microwaves and broadcast radio waves). The following chart
displays the important regions of the electromagnetic spectrum.

Figure 3.1:

The Electromagnetic Spectrum
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3.1.1 Quasi-Elastic Light Scattering I Dynamic Light Scattering
Dynamic Light Scattering (DLS), also known as Photon Correlation Spectroscopy or
Quasi-Elastic Light Scattering (QELS), is widely used in determining the size distribution
profile of small particles, diffusion coefficients, and molecular weights of polymers in
solution.
The incident light on the particle scatters in all directions, and one is able to
determine the distribution of the particles' movement by measuring dynamic fluctuations
intensity of scattered light. The intensities of the scattered light are determined by size,
shape and molecular interactions in the scattering particles. Light scattering is a valuable
tool for measuring molecular weight, radius of gyration, translational diffusion constant
and so on. 287
When the laser light strikes the dispersed particles or macromolecules suspension in
a medium, it is interacting with randomly moving particles. The intensity of the
fluctuating scattered light at a different angle and time will depend upon the size of the
particles. The small particles move faster than the big particles. These fluctuations occur
due to Brownian motion; analysis of the fluctuation will yield the velocity. The velocity
ofBrownian motion is measured as the translational diffusion coefficient. This
translational diffusion coefficient (D) can be related to particle size through the Stoke
Einstein equation. Therefore, it is possible to estimate the size of distribution, diffusion
coefficient and the hydrodynamic radius of a molecule from DLS measurements.288-290
The molecular weight measurements are usually obtained by static light scattering;
however, there are a few advantages for using dynamic light scattering techniques to
determine the molecular weight. For example: (i) it can be used to analyze the broad
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distributions of species of wide molecular masses; (ii) its high sensitivity allows detection
of very low amounts

«

0.01%) of higher mass species; (iii) there is no mass loss during

the measurement (not like chromatography method, SEC); (iv) time saving due to a short
experimental time; (v) automation; (vi) a modest development costs for using LS
instrument.
The major parts of the light scattering instrument include a monochromatic coherent
laser as a light source, photon detector and auto-correlator (Figure 3.2). When a laser
light beam passes through the sample, that light is scattered by particles at all angles. The
scattering light passes through the photon detector which detects the scattered light at a
given angle. The purpose for using the same scatter angle is to produce the identical
mean size particles.

The fluctuations of scattered light are converted into electrical

pulses and pass the digital correlator. The auto-correlator generates the autocorrelation
function for data analysis.
Polydisperse samples (with a broad distribution of particle size) have shown a
number of modes in DLS measurement, such as a main peak: and aggregation
information. Measuring the intensity of fluctuations at a given scattering angle can
provide information about the scattering particles hydrodynamic radius. When particles
in a suspension diffuse through the suspending medium, the effective radius of an
irregularly shaped particle is called the hydrodynamic radius of a particle.

{

I
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Figure 3.2: Schematic diagram of a conventionalt 900 dynamic light scattering
Instruments
A conventional dynamic light scattering instrument is including:
A monochromatic coherent laser (light source) with a fixed wavelength of
633nm; a focusing lens, one detector only detects the scattered light at one
angle (usually 90 0 ), a digital correlator.
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3.1.2 Theory
As spherical monodisperse non-interacting particles are placed in a dust-free fluid;
the scattering light will mutually interfere in different directions. In reality, all the scatter
particles are undergoing Brownian motions and leads to fluctuations of the scattered
intensity I (t). Dynamic light scattering is measuring the intensity of fluctuations which
is recorded in the time domain via a time autocorrelation function. The scattered light
intensity in time t is described as I (t); in a very short time, the intensity of the scattered
light is described as I (t+t). As time goes on, the measured intensities will no longer
correlate to the beginning state due to there is no similarity between the starting state and
the current state. The light-scattering spectrum can be obtained from the autocorrelation
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function of the scattering light intensity. A characteristic autocorrelation function (Eq.l)
ofthe scattered light is shown below where intensity (I) can be detennined
experimentally.
As the particle moves through the beam the intensity reaches a maximum and then
decays. The decay time of the correlation function is inversely proportional to the line
width of the spectrum. The decay of the autocorrelation is described by an exponential
decay function G (t) which relates the autocorrelation to the diffusion coefficient (D) and
the measurement vector K. Therefore, the diffusion coefficient and either particle size or
viscosity can be found by fitting the measured correlation function to a single exponential
function. The decay of the autocorrelation is described by an exponential decay function
in equation 2.

Equation 1:

Autocorrelation Function

Equation 2 : Decay of Autocorrelation

Equation 3 : Monodisperse Particles- Correlation Function

G(r) = Aexp(-2fr) + B
G (t): the sum of all exponential decays contained in the correlation function
baseline of the correlation function
intercept of the correlation function
r : decay constant proportional to the diffusion coefficient (D)

A:
B:

I
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Equation 4: Polydisperse Particles: Correlation Function

gJ: Sum of all exponential decays contained in the
Correlation Function

Equation 5: Decay Constant

D: Translational Diffusion Coefficient
q: (41t n/~) Sin (8/2)
n: Refractive index of solution
~: Wavelength of Laser
8: Scattering angle

Diffusion coefficient:
By fitting the points of the autocorrelation to the function G (t), the diffusion
coefficient can be measured and related to the equivalent sphere of diameter d using the
Stokes - Einstein equation (Equation 8). The diffusion coefficient (D) ofthe particles
can be calculated in the following equation.

Equation 6: Diffusion Coefficient (D)

TKB

D=-,;;;;..
3TCTJd

T

: Absolute temperature
KB : Boltzmann constant
17 : Viscosity

I
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Equation 7: Frequency of the Scattering Light

e

2nn

K = - Sin (-]
A
2
K is a constant related to the frequency of the scattering light (A)

n: Refractive index of the medium
.A.: Laser wavelength
0: Scattering angle

With the assumption that the particles are spherical and non-interacting, the
hydrodynamic radius can be calculated from the Stokes-Einstein equation. The
hydrodynamic radius is calculated based on an equivalent sphere with the same diffusion
coefficient.

Equation 8:

Stokes-Einstein equation

r=

kT
6n:1}d

r hydrodynamic radius (m)
k = Boltzmann constant (J1K=kg·m2/s 2 ·K)
T = temperature (K)
'll = solvent viscosity (kg/m's)
d = diffusion coefficient (m2/s)
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Figure 3.3: Example of Autocorrelation Function ofthe scattered light
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The dynamic scattering technique can be used to distinguish protein secondary
structures. The advantage of using dynamic scattering is the possibility to analyze
samples containing broad distributions of species of widely differing molecular masses
(e.g. a native protein and various sizes of aggregates), and to detect very small amounts
of the higher mass species. Commercially, dynamic light scattering is a rapid, reliable,
accurate and cost saving powerful tool for determining the size of particles and related
information. Also, sample concentration is not a critical issue for obtaining the needed
information. 291 -293 Actually, the main benefit is that the measurement doesn't require
solution or multiple concentrations like MALLS. Data can be obtained at a single
concentration.
In the present study, we apply the light scattering technique to measuring the

particle size of the cross-linked polymer nanoparticles and also studied the interaction
and aggregation between the polymer (PEl) and cross-linker.
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3.2 Nuclear magnetic resonance (NMR)
Nuclear magnetic resonance spectroscopy (NMR) is a prominent technique that
addresses many questions of structure and dynamics using the interaction ofradio
frequency electromagnetic radiation with matter. NMR spectroscopy is widely used by
chemists and biochemists to investigate the properties of organic compounds and
determine structure at the molecular level. Some isotopes are of particular interest to
organic chemists e.g., IH, J3e, 19F and 31p, which have spin of
ofNMR makes it pervasive in scientific research.

i (1

Y2). The versatility

NMR has the capability to perform

multi-dimensional and multinuclear experiments. One-dimensional NMR spectroscopy
is commonly used to elucidate simple chemical structure. Some advanced applications of
NMR techniques can be used to assist scientists to investigate further details in the
determination of molecular structure, such as multidimensional NMR, solid state NMR,
and gradient enhanced spectroscopy.

3.2.1 31 P NMR and IH NMR
We will not attempt to discuss the basic theory of the I H or 31 P NMR.

IH

NMR and

31 P NMR are important analytical tools for structure elucidation in chemistry, biology
and medical science. The 31 p NMR spectroscopy has proven to be a useful technique in
probing the secondary structure of DNA and RNA in solution. The 31p nuclei, with 100%
natural abundance and spin.!., are sensitive to the environment (such as o-p-o bond
2

angle and p-o torsional angle)?94-295 We have used 31p NMR to investigate the binding
interaction between quadruplex DNA and polymers.
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3.2.2 Diffusion NMR
Many methods for structure elucidation ofsmall molecules and proteins have
been well established for many years. The study of the solution behavior of molecules,
proteins and nucleic acids for aggregation or interaction properties in solution are
interesting fields for biochemical science. The intermolecular interactions, molecular
recognition processes, and binding behaviors at the molecular level provide essential and
important information for understanding the biological activities ofmolecules. Nuclear
magnetic resonance spectroscopy is the method of choice for studying molecular
dynamics in chemical and biological systems?96-298
In the past years, diffusion NMR methods have become useful for measuring

diffusion in solution. In principle, translational diffusion is one of the most basic forms
oftransport in chemical and biological systems. When diffusion occurs in a
homogeneous medium it will be a free and isotropic diffusion. The diffusion coefficient
will reflect the shape and size ofa molecular species; which provides information on the
molecular aggregation as well as size and structure oflabile systems. Diffusion NMR
measurements are now widely used to explore and understand the interactions and shapes
ofthe diffusion molecules.304-308
Diffusion NMR spectroscopy is commonly used to examine closely separated
mixtures, or to screen ligands for binding interactions. It can give unique insight as a
reliable guide for measuring the apparent molecular weight, secondary and tertiary

. . accred'It It. as a specla
. I chromatograph'IC meth0 d C'.lor
structures. 304-308 Sorne SCIentIsts
physical component separation.
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The diffusion ordered spectroscopy, or DOSY, experiments provide a way to
separate the different compounds in a mixture based on the differing translation diffusion
coefficients. Diffusion is analyzed in the DOSY experiment by observing the exponential
decay of the NMR signal due to the diffusion taking place between a coding and a
decoding gradient. The pulse field gradients methods are used as a direct or indirect way
to probe molecular dynamics in solutions. The diffusion measurement usually carries out
by observing the attenuation of the NMR signals during a pulsed field gradient
experiment. During the experiment, a series ofNMR diffusion spectra are acquired as a
function of the gradient strength. The degree of attenuation is a function ofthe magnetic
gradient pulse amplitude (G) and is proportional to the diffusion coefficient (D) of the
molecule. The vertical axis shows the corresponding diffusion constants (D) of the
molecules; the horizontal axis is encoded the chemical shift of the nucleus observed (such
as IH). The molecular structural properties and size relationships can be obtained from
the diffusion coefficient constant. 309

3.2.3

IH NMR: Diffusion Experiment

In proton diffusion experiments, there are two gradient pulses applied: one before
the refocusing 1800 pulse and the other is after the 1800 pulse. These two gradient pulses
are identical in amplitude (G) and width (d). They are separated by a time (0) and are
placed symmetrically about the 1800 pulse. The first gradient pulse is to dephase
magnetization according to its position in the NMR tube. During the subsequent 0 period,
the spins are left to evolve and diffuse. Their chemical shift is refocused by applying the
usual 180° pulse. At the end of the 0 period, the spins that have diffused to a new
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location in the NMR tube will not be refocused by the second gradient and will therefore
attenuate the signal. These gradient pulses have no effect on stationary spins. During the
experimental process, the echo time is left constant while the gradient strength G is
varied (usually along the z-axis). The loss of magnetization can be plotted against the
gradient strength to extract the diffusion coefficient D.

Figure 3.4: Example of the IH NMR: Diffusion Experiment
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The self-diffusion coefficient for Brownian spheres is given by the StokesEinstein equation. The Stokes-Einstein Equation (equation 8) relates the diffusion
coefficient (D) of a particle to its molecular shape via a friction coefficient (f) and
temperature.

Equation 9: Diffusion Coefficient (D)
D=KT/f

T : Temperature (Kelvin)
K: Boltzmann constant
f : Fraction coefficient

I1

\
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lithe solute is considered as a spherical particle with the effective hydrodynamic
radius (RD) in a solution of the viscosity (11); the friction coefficient (t) is given as the
following equation. It should be noted that different theoretical descriptions are needed
to describe the hydrodynamic frictional coefficient (t) for molecular species of different
geometries.

310-312

Equation 10: Friction Coefficient (t)
f=62t 11 RD
f: Friction coefficient
RD : hydrodynamic radius
11: solution viscosity

Indeed, the diffusion coefficient factors are affected by molecular shape, size,
solvent viscosity, and the solution properties such as salt concentration, pH, and
temperature, etc. It is well known that molecular self-diffusion coefficients (D) are
measured by a pulsed field gradient spin-echo NMR experiment. Three most practical
gradient field methods are pulsed gradient spin echo (POSE), pulsed field gradient
stimulated spin echo (PFO-SSE) and bipolar pulse longitudinal eddy current delay (BPP·
LED). This technique is based on the application of the gradient field, which encodes
and decodes the translational diffusion motion of the components in samples. To obtain
the diffusion coefficient distribution from these experiments, the signal attenuation is
detected and it depends on the gradient strength, the delay time between the pulse
gradients and the diffusion coefficient of the molecules. Using the pulsed field gradient
method, motion can be measured by evaluating the attenuation of the spin·echo signa1. 313
The attenuated signal (A) can be calculated by the following equation.
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Equation 11: Attenuated Signal (A)

A
=
Ao

-

22 ..2

exp l G g a

d
(T- - )]

3

D

A: Measured peak intensity
Ao: Maximum peak intensity
D: Translational diffusion coefficient ~in cm2/s)
g: Gyromagnetic ratio (2.675 I 97x 10 G- 1S-1 for IH)
d: Duration of gradient
T: Diffusion time (time between gradients)
G: Gradient strength (G/cm)

Data are plotted according to the following equation and D is calculated as the slope.

Equation 12:

The self-diffusion constant is measured in m2 S·l. Smaller molecules have larger
D values (diffuse faster); the larger molecules move more slowly with small D values.
The Stokes-Einstein equation assumes spherical molecules that are much larger than the
solvent molecules.

3.2.4. Nuclear Overhauser Effect Spectroscopy (NOESy)
The Nuclear Overhauser Effect (NOE) is the transfer of nuclear spin polarization
from one nuclear spin population to another via cross-relaxation. The nuclear spins
undergoing cross-relaxation are those which are close to one another in space, and the
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effect decays at a rate of,-6 (r is the distance between the two nuclei). Thus, only atoms
within a close distance (smaller than 5A) can give a nuclear Overhauser effect. The spin
spin coupling can be observed by short-range dipolar couplings through close proximity
in three-dimensional space.
NOESY, two-dimensional nuclear magnetic resonance spectroscopy (20 NMR),
is one of the widely used techniques to study the conformation of molecules. NOE's are
observed as the cross-peaks between two coupled nuclei. NOESY cross peaks of a
spectrum indicate which protons are close in space. Thus, NOESY will allow for an
estimation of the inter-nuclear distances and can provide precise molecular
conformation. 3 14-315 The NOESY spectrum can provide all possible correlations
information such as the nuclear Overhauser effect, chemical exchange and
conformational exchange to provide insight into molecular conformation and
dynamics? 15

3.3

Ultraviolet-Visible Spectroscopy (UVNis)

UVNis absorption spectroscopy (sometimes called electronic spectroscopy) covers
the ultraviolet-visible region ranging from the near-UV to the near-IR. The absorption
measures electronic transitions from the ground to the excited state as a function of
frequency or wavelength due to its interaction with a sample. UVNis spectroscopy is
commonly used in the quantitative determination of solutions of transition metal ions and
highly conjugated compounds. The UV and visible wavelength ranges are from 190 to
800 nrn. Figure 3.5 displays the visible spectrum ranges from 400 nrn to 800 nrn.

Absorption of ultraviolet and visible (UV-Vis) radiation in both atoms and
molecules is associated with excitation of electrons from low energy to higher energy
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levels. The electron transition can either emit or absorb the energy. Most of the
absorption in the UV-Vis spectroscopy occurs due to n-electron transitions or n-electron
transitions within the molecules. Bonding to anti bonding (n - n*) and non-bonding to
antibonding (n - n*) transition usually occur in UVNIS spectroscopy. The energy of
light absorbed energetically is from the highest energy bonding n-orbital (HOMO) to the
lowest energy antibonding n-orbital (LUMO). Figure 3.6 shows the diagram of the
electron transition between the bonding, non-bonding and anti-bonding orbitals.

Figure 3.5: Diagram of visible spectrum wavelength (400nm -800nm)
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Figure 3.6: Diagram of the electron transition between the bonding,
non-bonding and anti-bonding
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UVNis can be used in a wide range of analytical applications to measure the
absorptive behavior of substances. The most routine measurement for UV-Vis is used as
qualitative or quantitative analysis ofthe sample species. The qualitative measurement is
served as identification for determining the molecular species, in which a given
molecular species absorbs light in specific regions of the spectrum. For example, UVNis
can be used in HPLC detector to identify the unknown analyte species. The quantitative
analysis is measured the beam of radiation through a sample and detects the intensity of
radiation that passes through the sample. The Beer-Lambert law is often used as a
quantitative method to determine concentrations of absorbing species in solution. The
absorbance (A) is directly proportional to the concentration ofthe absorbing species in
the solution and the path length. Thus, UVNis spectroscopy can be used to determine the
concentration and molar absorptivity of the compound in dilute solution. 316 The molar
absorption, known as molar extinction coefficient (s), is measured the molecule absorbs
light at a particular wavelength.

Equation 13: Beer -Lambert Law

A= ebC
A: absorbance (no units, since A = 10glO (10 I 1)
s: molar absorptivity with units of L mor l cm")
b: the path length of the cuvette (cm).
c: concentration of the compound in solution, (mol L"I)
I: Intensity
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Figure 3.7:

A Diagram of a Double Beam Spectrometer

Diagram adapted from www. chemguide.co.uklanalysisluv-visible/spectrometer

3.4

Circular Dichroism (CD)
3.4.1 Basic Theory
Circular dichroism (CD) is a chiroptical method which can be used to measure the

differential absorption ofrotational plane-polarized light of optically active compounds.
The interaction between the chromophores in the chiral field introduces the perturbations
leading to optical activity. CD measures the difference of the absorption of right- and
left-handed circularly polarized light from chiral molecules. CD spectroscopy is used
extensively to study higher order structures of chiral (asymmetric) macromolecules ofall
types and sizes, particularly in proteins and DNA. The wavelength range of CD is
included far UV, ultraviolet light as well as infrared light. The UV light range from180
300 nm is most commonly used in CD for DNA measurement because the DNA bases
absorb light in this range.
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The majority of biological molecules are chiral compounds. CD is sensitive to
the conformational changes, structure and stability of the secondary or tertiary structure
of proteins and DNA. CD spectroscopy can provide the representative structural
information about the molecules, such as kinetic and thermodynamic information on
macromolecules. Therefore, circular dichroism makes it an attractive and powerful tool in
the biomolecule field. 317
The CD instrument measures the difference in left (L)and right (R)-handed
absorbance of the circularly polarized light, (AA= AL-AR)

A more convenient

characterization of CD is the difference in the molar extinction coefficients, 8 E (Delta
Epsilon) is a function of wavelength which typically corresponds to an ellipticity (9) and
is expressed in millidegrees. 318

= AL (A.) - AR (A.), where A. is the wavelength.

Circular dichroism (CD):

M (A.)

Molar circular dichroism (88):

8E =EL -ER (EL and ER is molar circular dichroism
ofleft and right circularly polarized light)

Molar extinction coefficients:

EL :

ER :

Molar concentration:
Path length:

left circular polarized light (LCP)
right circular polarized light (RCP)

C (giL), C is concentration
I (centimeters).

!J. A= (EL -CR) CI, measured as degrees of ellipticity

If a right (R) and a left (L) circularly polarized wave of equal amplitude, are
superimposed, the result is plane-polarized light. Figure 3.8shows how the E vector of
each will sum up in part A. Similarly, plane-polarized light can be decomposed into R
and L components. If the amplitudes of the two circularly polarized waves are not the
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same, the resultant E vector will follow an elliptical path and such light is said to be
elliptically polarized. Elliptical polarized light is composed ofunequal contribution ofER
and EL circular polarized light. The degree ofellipticity (8) is defmed as the tangent ofthe
ratio of the minor to major elliptical axis. Linear polarized light has 0 degrees of
ellipticity. Figure 3.9 shows the examples ofthe left-handed and right-handed ellipticity.
Degree of ellipticity [8] =3298.2 A E

Figure 3.8: Elliptical Polarization

Ell
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ER : magnitude of the electric field vector of right-circularly polarized light
EL : magnitude of the electric field vector of left-circularly polarized light
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Figure 3.9:

Example of the left-handed and right-handed ellipticity (9)
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A circular dichroism signal is defined as positive or negative, depending on
whether L-CPL(circular polarized light) is absorbed to a greater extent than R-CPL (a
positive CD signal) or to a lesser extent ( a negative CD signal). The CD instrument is
quite sensitive and is capable of measuring with millidegree precision.
CD is a particularly powerful technique for examining the conformational
changes of proteins and nucleic acids. CD is usually used in monitoring the structural
changes due to changes in environmental condition, such as temperature, ionic strength,
denaturants and pH.
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The advantages of using CD spectroscopy are as follows: (1)

very little amount of sample is required in biological buffers (200~1 of 0.5 mg/ml solution
in standard cells), (2) CD will not destroy or decompose the compound and (3) CD can
be monitored very accurately. One drawback of CD measurement is interference by
solvent absorption in the UV region. For better performance in CD measurement, the
sample is required to be in dilute solution with non-absorbing buffer for measurements
below 200 nm. Figures 3.10 and 3.11 give examples of CD spectra to provide useful
references for a variety of nucleic acid structures, ranging from single-stranded to
quadruplex forms. Single strand has one positive peak at 276 nm and one negative peak
at 250 nm. Duplex DNA has one negative at 246 nm and two positive peaks at 260 nm
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i

and 285 run . Parallel quadruplex DNA has one negative peak at 236 run and one positive
peak at 270 nm. The antiparallel quadruplex DNA show two positive peaks at 246 nm,
300 nm and one negative peak at 260 nm.
Figure 3.10:

Example of typical reference spectra of single strand and duplex DNA
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Adapted from Bishop, G. R. et ai, Current Protocols in Nucleic Acid
Chemistry,1003.

Figure 3.11: Typical reference spectra of parallel and anti-parallel quadruplex
DNA
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CHAPTER 4 MATERIALS AND METHODS

4.1

Materials
Polyethylenimine, high molecular weight, water -free polymer (Mw 25000 D, unit

molecular weight 45 D) was purchased from Aldrich (St. Louis, MO, USA). The cross
linking agent, isophthalaldehyde, 97% and D20 deuterium oxide 99.9 atom % D were
also purchased from Aldrich. The phosphate buffer solution was prepared with 5 mM
.KH2P04,5 mM K2HP04, 1 mM EDTA at pH 7.0. All the solid buffer chemical

compounds were purchased from Sigma Chemicals. EDTA disodium salt was purchased
from Fisher. Tris buffer solution was prepared and the pH adjusted with concentrated
KOH to pH 7.1. TRIZMA BASE was purchased from Sigma-Aldrich. Tris HCl was
purchased from J.T Baker. Potassium chloride was purchased from Fisher Scientific.
Dichloromethane was purchased from PHARMCO-AAPER, HPLC grade. The 0.21lm
filters were purchased from Millipore Corporation. The DNA primer TTTTGGGG was
purchased from Invitrogen or Sigma Aldrich (St. Louis, MO) (custom primers, 5' to 3'
TTTTGGGG). 5,10,15,20-tetrakis (l-methyl-4-pyridyl)2IH,23H-porphine,tetra-p
tosylate salt -Porphyrin (HzTMPyP) was purchased from Aldrich. Polyvinylpyridine,
polyallylamine, poly (L-lysine), polyethylene oxide (PEO), poly(4-vinylpyridinium
bromide), poly(4-vinylpyridine N-oxide), poly(N-vinylpyrrolidone); poly( ethylene
glycol), Poly(L-omithine)HCl, poly(2-vinylpyridine), Poly(4-vinylpyridine) were
purchased from Polysciences. Metafectene Pro and Metafectene Easy are a gift of
Biontex, poly (2-ethyl-2-oxazoline) with the MW200,000 and 50,000 were purchased
from Alfa Aesar Company. The polymers were used without further purification.
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4.1.1 Buffer Solutions
Potassium phosphate buffer solution (KPBS): lOX KPBS was prepared and utilized
as a stock solution to prepare subsequent working buffer solutions for samples. Table 2
shows the KPBS 10X stock solution preparation. The reagents were weighted and
transferred into the volumetric flask (IL) and Q.S with the milli Q distilled deionized
water. The buffer solutions were mixed well and filtered through a 0.45

}11Il

filter (stored

at 4°C).
Table 2: Potassium Phosphate Buffer (KPBS) lOX Stock Solution
Reagent

Molecular Weight

Grams(g)

Moles

Monobasic KH2P04

136.09

5.716

0.042

Dibasic K2HP04

174.18

10.102

0.058

K2EDTA:2H 2O

404.5

0.405

0.001

Working solutions were prepared by transferring 100 mL ofthe KPBS stock
solution (10X) into I L volumetric flask and QS to the volume. The buffer solution was
then adjusted to pH 7.0 by adding KOH (1M) solution.
Tris buffers were prepared by adding 2.9 g ofTris-HCI, 0.072 g ofTRIZMA BASE
and 10.8 g of potassium chloride into one liter of distilled water. The buffer solutions
were mixed well and adjusted with KOH to pH 7.1, then stored under 4°C condition.
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4.2

Methods

4.2.1

DNA Preparation

4.2.1.1 Dialysis Procedure
The purpose of the dialysis treatment of the DNA oligomers is to ensure the
purification of the oligomers. Dialysis tubing from Spectro-Pro industries with a 1000
molecular weight cutoff (MWCO) pore size was used for DNA dialysis. Pre-treatment of
the dialysis tubing to remove the preservative before use is required. The dialysis tubing
was placed in DI water and heated to boiling, and sodium carbonate was added, along
with EDTA and boiling continued to one hour. After the solution was cooled, the
solution was removed and replaced with a large amount of distilled water. The magnetic
stirring bar was placed in the bottom of the beaker to keep the water agitated. This
procedure needed to be repeated several times to ensure that all the preservatives were
removed. After the pre-treatment, the dialysis tubing is stored at 4°C in the refrigerator
for future use.
If the DNA oligomers are not HPLC grade, the DNA must be purified by dialysis
before use. The DNA samples were placed into dialysis tubing with a large amount ofDI
water with continuing stirred during the procedures. The water was changed every 4
hours and this was continued for 48 hours. These procedures were repeated several times
to ensure the complete removal of any unwanted salt from the oligomers.
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4.2.1.2 Quadruplex DNA Preparation
DNA stock solutions were prepared just prior to use by reconstitution of the
oligomer in purified distilled water. The dry oligomers were reconstituted into a given
volume of DI water depending on the DNA concentration needed. The oligomers were
reconstituted into DI water, and then each sample solution was lyophilized at room
temperature to remove the water. Unused portions of the stock samples were stored
frozen at -20°C. The DNA concentration was determined by UV-Vis (CARY 100 Bio
UV-Vis Spectrophotometer, Varian Company). The concentrated stock solution of DNA
was diluted before the measurement. The concentration of the T4G4was calculated
spectrophotometrically using the Beer's Law (A= e be) equation.
The milli-Q purified deionized water was used to prepare the buffer solutions.
Appropriate amounts of the DNA stock solutions were aliquot for analysis, lyophilized,
and reconstituted into buffer. In this experiment, the dry oligomers were reconstituted
into 1 mL of potassium phosphate buffer (5 mM KH2P04. 5 mM K2HP04, 150mM KCI,
pH 7.0) prior to quadruplex formation. The sample solution was treated in water bath at
95°C in a Fisher Scientific, model 9100 water bath for 2 minutes and slowly cooled down
to room temperature. This process was done by heating the samples in a dry water bath,
then turning the power off after 2 minutes, and letting the samples cool to room
temperature slowly within the heating block. Slow cooling is to ensure a slow annealing
ofthe DNA and subsequent formation of stable quadruplex DNA. The samples were
equilibrated for 48 hours at 4 °C prior to analysis. The formation ofquadruplex DNA
structure was verified by circular dichroism measurement. The gel electrophoresis (SDS
PAGE) also confirmed the formation of the quadruplex T4G4structure.
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4.2.2

Polyethylenimine Intra-Molecular Cross-Linking

4.2.2.1

Intra-molecular cross-linking (in solution)

The stock solution of saturated isophthalaldehyde was prepared by adding the
appropriate amount of the compound in water. This saturated solution was filtered
through filter paper to remove any undissolved material. The PEl solutions were prepared
with different concentrations. The PEl solution was added to a saturated
isophthalaldehyde in a drop-by-drop manner. The resulting solution was stirred for two
hours. After two hours reaction time, the solution was precipitated by adding 2-propanol.
The precipitated solid was air dried and re-dissolved into D 20 for NMR experiments.

4.2.3

Cross-Linking Examined by NMR Experiment
The VARIAN INOVA 500 MHz MNR Spectrometer System was used in IH in situ

study. This NMR spectrometer is interfaced to a workstation that controls the NMR via
the Varian software.

4.2.4

In Situ Study
The IH NMR in situ samples were prepared by adding a sufficient amount of

isophthalaldehyde into D 20 solution. Due to the low solubility of the isophthalaldehyde,
the excess amount of the isophthalaldehyde was filtered through the filter paper. The
clear solution was used to run IH NMR as isophthalaldehyde standard spectra. The
polyethylenimine 1H NMR sample was prepared by transferring the sufficient amount of
compounds into 5 mL ofD20. In order to identify the optimum PEIIisophthalaldehyde
ratio in this study, the concentration ofthe corresponding polymer solution was adjusted
to produce different ratios. The PEIIisophthalaldehyde ratio was prepared at 5, 15, 25,67
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and examined by in situ IH NMR. The NMR spectra were recorded on GE 300 MHZ
spectrometer at different time points.

4.2.5

Identify the Intra- Molecular Cross-Linking by Organic Solvent Extraction
and Examined by UV-Vis

4.2.5.1 UV-Vis Experiment
A Cary 300E Bio or Cary 100E spectrophotometer (Varian, Inc.), interfaced to a
Windows based computer with CaryNarian Win UV Bio version 2.0 software, was used
for studies. Both spectrophotometers are equipped with a Peltier thermoelectric heating!
cooling system which include a multi-cell device and a sample compartment.

The

spectrophotometers have the capabilities of using either external probe to measure the
temperature inside of sample cuvette or the ability to use the cell block to measure the
temperature of the sample compartment.
To effect the intramolecular cross-linking formation, the stock solution of PEl was
prepared at 0.0184 M. The isophthalaldehyde stock solution was prepared at 0.0012 M.
The volume ratio of the PEl and isophthalaldehyde was prepared at 1: 1, 3: 1, 5: 1 and 16: 1.
The equivalent mole ratio of the PEl (by monomer mass)/ isophthalaldehyde
was 15,45, 75 and 240.
The extraction samples were prepared by adding the dichloromethane into the cross
linked sample with 1 to 1 ratios. The mixtures were shaken for 10 min and allowed to
stand for 20 minutes to separate the top and bottom layers. The pure isophthalaldehyde
extraction sample was used as a control sample. The PEIIisophthalaldehyde mole ratio
at 75 and 240 were prepared in the same manner with the same volume of the
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dichloromethane. All the samples were prepared with potassium phosphate buffer at pH
7.0. The samples were analyzed using an Olis HP 8452 A Diode Array
Spectrophotometer.

4.2.5.2

Intermolecular Cross-Linked PEl: bulk preparation

The bulk samples were prepared by transferring I g of water free 25 kD
polyethylenimine into a beaker and adding 0.1 g of the isophthalaldehyde. The mixture
was placed into a water bath and stirred for 15 minutes under 100°C temperature control.
This process was to remove any remaining water from PEL The products of the PEl and
isophthalaldehyde mixture turned into a yellow solid color. In order to test the solubility
in water, a sufficient amount of water was added into the final products and stirred for 30
minutes. The PEl and isophthalaldehyde cross-linked bulk samples remained solid yellow
color materials. The bulk samples continued to stir overnight and the remaining
compound was still insoluble in water. This observation provided the indications that the
bulk PEIIisophthalaldehyde reaction formed intermolecular cross-linked PEL

4.2.6

Characterization of Particle Size by Light Scattering (QELS)
Light scattering spectroscopy was performed in a Wyatt Dawn EOS light scattering

spectrometer (Wyatt Technology Corporation). The Wyatt spectrometry has provided the
multi-angle light scattering (MALS) detector and the quasi-elastic light scattering
detector (QELS) selection. The MALS-QELS system can be used to measure radius of

J and radius of hydrodynamic (rh) at the same time; the radius of gyration is

gyration (r

determined from the angular dependence of scattered light intensity. The radius of
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hydrodynamic is measured the fluctuation of the light scattering of the diffusion
molecules. MALLS utilized 18 detectors at various angles, ranging from 15° to 180°;
each detector was nonnalized to the 90-degree detector using an isotropic scatterer
standard.
The molecular aggregation behavior was studied by dynamic light scattering. The
measurements were performed at 4°C with an incident laser light beam of 685 nm at a
scattering angle of 90°.320 Polyethylenimine solutions were prepared at concentrations of
0.1 M and 1.8 M in phosphate buffer at pH 7.0. Water was pre-filtered through 0.02 Jlm
Whatman nanotop filters before being used to prepare the solution. The sample solutions
were filtered through 0.2 Jlm filters prior to use and stored at 4°C. The isophthalaldehyde
solutions were prepared at 0.004M in a phosphate buffer solution. The solutions were
filtered through 0.2 Jlm filters and stored under 4°C condition. The isophthalaldehyde
was titrated into the PEl solutions. The mixing solution was stirred for 10 minutes
followed by 2 minutes of sonication. The molecular cross-linking reaction was perfonned
by dynamic light scattering to investigate whether the formation of inter-molecular cross
links (aggregation) or intra-molecular cross-links.

4.2.7

PEl I Quadruplex DNA Circular Dichroism Study

Circular dichroism measurement was carried out using a 62 A DS AVIV CD
spectropolarimeter (Aviv Associates, Lakewood, NJ) equipped with a multi-cell holder.
The temperature ofthe Peltier heating/cooling device was assisted by an Isotemp water
bath model 9100 (Fisher Scientific). A cold water supply circulates around the Xenon
lamp to prevent overheating. The spectrophotometer was interfaced to a DOS-based
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computer. The AVN version 3.14 software was used for data collection and processing.
A nitrogen purge was used to eliminate any moisture on the optics. Cuvettes were
scanned versus water prior to experiments to ensure that no CD active impurities
remained in the cuvettes. CD measures the interaction of circularly polarized light with
molecules. All CD spectra were read from 210-320 nm at 1.0 nm increments with a
bandwidth of Inm and a time constant of 1.0 sec at 25°C.
Samples were prepared by reconstituting lyophilized DNA oligomer into 100 mM
phosphate (K+) buffer solution (PH 7.0). The experiment was performed by titration with
pre-mixed DNAIIOx PEl solution. This procedure is designed to keep the DNA
concentration constant. The DNA-PEl titration was conducted by adding the stock
solution of DNAII Ox PEl stepwise (aliquot of stock) directly to 250 ilL of starting
volume of DNA in solution. CD spectra were measured subsequently after the spectra
were stabilized. The stock concentration of the quadruplex DNA was 47 11M. 50 ilL of
DNA stock solution was transferred into 450 ilL buffer solution which was made up the
final quadruplex DNA concentration at 4.7 11M. The stock solution of PEl was 470 11M.
The DNAIIOx PEl pre-mixed solution was prepared at 500 ilL for the titration purpose.
The DNA pre-mixed solution was transferred 1 III and 20 III of the each aliquot into
cuvette of250 III of DNA (4.7 11M) solution. This fixed quadruplex DNA concentration
is used to more readily monitor changes in the structure.
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4.2.8 Polymers Screen Using UV-Vis Spectroscopy Studies
To investigate the interaction between polymers and quadruplex DNA, optical
studies were carried out using the tetra (N-methylpyridyl) porphyrin as a probe. The
polymers used in this study are the following: poly(2-vinylpyridine-N-oxide),
polyallylamine, poly (L-Iysine), poly(4-vinylpyridinium bromide), poly(4-vinylpyridine
N-oxide), poly(N-vinylpyrrolidone); poly( ethylene glycol), poly(L-omithine)HCI,
poly(2-vinylpyridine), poly(4-vinylpyridine), and the lipid agents Metafectence Pro,
Metafectence Easy. All experiments, except where specifically indicated, were
performed at 2SoC in potassium phosphate buffer at pH 7.0. The concentration of the
polymer solutions was varied according to their solubility in phosphate buffer. A stock
solution of the porphyrin was prepared at a concentration of S JlM and stored in
phosphate buffer. The porphyrin solution must be protected from light to prevent
degradation. The order of the experiment is as follows:

1.) UV-Vis ofporphyrin solution used as a control spectrum.
2.) Addition of quadruplex DNA into porphyrin solution, measurement of the UV
spectrum.
3.) Addition of polymer into the DNA / porphyrin mixed solution, measurement ofthe
UV spectrum.
The porphyrin UV maximum peak (Soret band) is at 422 nm when it is a free
porphyrin. The UV spectrum of the maximum peak of the quadruplex DNA/porphyrin
complex was observed at 433 nm. When polymer is added to the DNA /porphyrin
complex, the Soret band may stay at 433 nm (DNA-porphyrin complex intact) or shift
back to 422 nm (DNA-porphyrin complex disrupted).
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4.2.9

lip NMR

All

31p

Study: Binding Interaction of Quadruplex DNA I Polymer

NMR experiments were carried out on a Bruker DPX400 NMR

spectrometer equipped with a BBFO broad-band probe. The spectra were taken at

31 p

frequency of 161.975 MHz, with a spectral width of 40 ppm, a 90° pulse of 9.2 fl s. The
spectra were referenced to an external 85% phosphoric acid sample (0 ppm). All spectra
were processed using Bruker TopSpin 1.3 software. The quadruplex (T4G4) DNA was
incubated in a saline solution at 150mM KCl at pH 7.0 (not in potassium phosphate
buffer) to avoid signal from the buffer. The deionized water containing KCI would lower
the buffer solution pH which will require the researcher to adjust the pH back to pH7.0
with 1M KOH. All polymers (polyethylenimine, poly (4-vinylpyridine N-oxide) and poly
(N-vinylpyrrolidone) were prepared with 98% D20.

4.2.10

Diffusion NMR Experiment

4.2.10.1 Sample preparation
DNA quadruplex (T4G4) concentrations were adjusted to range from 0.5-1.0 mM in
phosphate buffer (PH 7.0). Deuterium oxide (D20) was added to DNA samples prior to
loading into NMR tube. NMR samples were prepared about 500 ilL for the experiment.
Polymers preparation: The maximum concentration of the polymer depends on the
solubility of the polymer. Poly (N-vinylpyrrolidone) was prepared at 4 mM. Poly (4
vinylpyridine N-oxide) was prepared at 1 mM. PEl was prepared from 2 mM to 10 mM.
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4.2.10.2

Experiment conditions

All samples were prepared in 90%H 20/1O% D 20 in order to observe the
exchangeable imino proton of the G nucleotides. The ID and 2D IH NMR spectra were
obtained on a Bruker A vance 600 MHz spectrometer equipped with a triple-resonance
Tel cryoprobe, operating at 600.11 MHz for the proton frequency and using the
following parameters: 90°; pulse, 7.60-8.50 flS; 4-8 scans; recycle time 3-8 s; spectral
width 6000 Hz and 16-32 k data points.
The DOSY experiment spectra were recorded on Bruker A vance 700 MHz for
proton equipped with a pulsed gradient unit. The experiments used a stimulated echo and
bipolar gradient pulses for diffusion. 321 The duration of the magnetic field pulse
gradients (8) was optimized for each diffusion time (8) in order to obtain 1-5% residual
signal with the maximum gradient strength. The gradient strength was varied linearly
from 2% to 95% in 16 steps. The temperature was set and controlled to 300 K with an air
flow of 670 L per hour in order to avoid any temperature fluctuations due to sample
heating during the magnetic field pulse gradients. After Fourier transformation and
baseline correction the diffusion dimension were processed and analyzed using Bruker
Topspin 2.1 software.
2D DOSY experiments with a IH detection for quadruplex (T4G4) DNA and Poly
(N-vinylpyrrolidone) mixture sample were performed on a Bruker Avance 700 MHz
using stimulated echo and bipolar gradient pulses for diffusion.
2D DOSY experiments with 31p detection for quadruplex (T4G4) DNA and Poly (4
vinylpyridine N-oxide) samples were performed on a Bruker DPX 400 MHz NMR
spectrometer using the same pulse sequence as above.
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4.2.11 PEl and Quadruplex DNA Complex Structural Transition Study by CD

PEl samples were prepared at the concentration of3.76 mM and quadruplexes (T4
G4) DNA was prepared at the concentration of0.7536 mM. The DNA concentration was

detennined on the basis ofUV absorption at 260 nm of the sample measured in
phosphate buffer (PH 7) at 95°C. The molar extinction coefficient (71400 cm· 1M· I ) was
using the previous experiment data which was detennined by Beer Lambert law. The
samples were prepared using 1 to 1 and 1 to 5 molar ratio of the quadruplex DNA and
PEL The experiments were perfonned on Aviv Associates CD Spectropolarimeter Model
62-ADS. The data were collected every 1 nm. with averaging time of3 sec and
bandwidth of I in a 0.1 cm path length cuvette.
The time interval profile was carried out at initial. two and half and four hour for
quadruplex DNAIPEI complexes. The evaluations ofthe temperature influence on the
structures were also included in the study. The incubation temperature at 4°C and 9°C
were used to investigate the structural transition. All the experiment conditions are
described as above.
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CHAPTER 5

RESULTS AND DISCUSSION

5.1 Molecular Cross-Linking Studies
5.1.1 IH NMR investigates PEl cross-linking

Polyethylenimine is a well-known macromolecule for binding DNA. 322·323 Several
recent studies have been reported where the structure of PEl was altered to change the
nature of the macromolecule and its binding properties. 324 It was our intention to
develop a cross-linker for PEl, which would alter the DNA binding and allow for
molecular imprinting on specific DNA structures.
Accordingly, we examined the reaction of isophthalaldehyde (I ,3-benzene
dialdehyde) with PEl. Aldehydes and primary amines react to form imines. Purely
aliphatic imines are unstable in the present of water. When either the aldehyde or amine
is aromatic, such imines are relatively stable to hydrolysis.

The cross-linking of PEl by

isophthalaldehyde occurs when the two aldehydes react with two of the primary amine
(-NH2) groups found in highly branched PEl. Cross-linking could be intra-molecular
(both -NH2 groups on the same PEl molecule) or inter-molecular (-NH2 groups on
different PEl molecules). The cross-linking reactions were studied by a variety of
techniques including NMR, UV-Vis, and QELS.
First, cross-linking reactions were conducted in deuterium oxide and monitored by
IH NMR. The proton NMR spectra revealed that the cross-linker (isophthalaldehyde)
reacted with PEl very rapidly. We have found that the ratio ofthe PEIIisophthalaldehyde
is a critical factor for the formation of the intra-molecular cross-linking. When the ratio
of the PEIIisophthalaldehyde is low (high concentration ofisophthalaldehyde), the
mixing solution immediately formed chunks of white precipitate. These white solids were

96

insoluble in D20. When the PEIIisophthalaldehyde ratio is too high (low concentration of
isophthalaldehyde), few cross-links are fonned during the reaction. Table 3 showed the
observation results of bulk quantity reactions of PEl and isophthalaldehyde in different
ratio. The resulting white precipitate compounds were re-dissolved in D20 and examined
by proton NMR. The IH NMR spectra of isophthalaldehyde and polyethylenimine are
shown in figure 5.1 and figure 5.2, respectively. Figure 5.3 shows the IH NMR spectrum
of an initial time point of the PEl cross-linking reaction. The CHO proton resonance can
be observed at about 9.9 ppm. However, two hours after initiation of the PEl cross
linking reaction, the CHO proton resonance can no longer be observed in the IH NMR
spectrum (figure 5.4). Comparing figures 5.3 and 5.4, we have observed that the IH
NMR peak for the isophthalaldehyde CHO proton disappeared after reacting with PEl for
two hours. This indicates that the isophthalaldehyde has cross-linked the PEl molecules,
while the broadening of the aromatic isophthalaldehyde peaks also supports crosslinking.

Table 3: Summary of tbe PEII Isopbtbalaldebyde Cross~linking Reaction

PElIIsopbtbalaldebyde

Molar Ratio
lI8

PElIIsopbtbalaldebyde

25

Comment
Large white precipitate, cross-linking
reaction occurred immediately
Cross-Linking Reaction occurred

PElIIsopbtbalaldebyde

67

Cross-Linking Reaction occurred

PElIIsopbtbalaldebyde

75

Cross-Linking Reaction occurred

Note: The molar ratio in the experiment is mole PEl monomer/mole isophthalaldehyde
not moles PEl polymer/moles isophthalaldehyde.
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5.1.2 UV-VisfExtraction Experiments to Identify the Cross-linking Reaction
To show that isophthalaldehyde is being chemically incorporated into the PEl as a
cross-linker, the extraction studies were performed. The concept of the extraction
experiment was to examine whether the isophthalaldehyde could be removed by
extraction with dichloromethane. If isophthalaldehyde can be removed, the
isophthalaldehyde is not cross-linking covalently. If isophthalaldehyde cannot be
removed, this will support the cross-linking by covalent bonding. The UV-Vis spectra of
isophthalaldehyde and PEl were recorded as reference standard spectra.
PEl and isophthalaldehyde were prepared in stock solutions and aliquots were mixed
in different ratios. In figure 5.5 (A) shows the isophthalaldehyde and PEl reference
spectra ofUV-Vis absorption spectra. In figure 5.5(B) shows the UV-Vis absorption
spectra of different ratios of isophthalaldehyde and PEl before extraction (PEl!
Isophthalaldehyde from 1:1,3:1,5:1 and 16:1). From the spectra, we observed that
increasing the volume ratio of the PEl I isophthalaldehyde resulted in decreasing the
intensity of the PEIIIsophthalaldehyde (as expected with less isophthalaldehyde).
Table 4 summarizes the pre-extraction (before added dichloromethane) of the PEl!
isophthalaldehyde data in different ratios which were made by mixing stock solutions of
the PEl and isophthalaldehyde in the volume ratios. If absorptivity stays constant (no
change due to cross-linking) then we should find the predicted results same as observed
results. The volume ratio of the PEl and isophthalaldehyde was prepared from 1:1,3:1,
5:1 and 16: 1; we observed the decrease in % of relative amount of the isophthalaldehyde
at wavelength Amax (294 nm) from 42% to 6.3% (Table 4). When no PEl added, the Amax
absorption was observed 0.8868 absorption unit which is equivalent to the 100% of the
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relative amount of isophthalaldehyde. In I to I ratio ofPEI and isophthalaldehyde the
results shows a 0.3737 absorption unit at Amax, which is corresponded to 42.1 % of
relative amount of isophthalaldehyde (the expected value is 50%). In 16 to I ratio of
PEIIlsophthaiaidehyde, the !.max is decreasing to 0.0565 absorption unit which is
corresponded to 6.3% of isophthalaldehyde remaining in the solution mixtures (expected
value is 5.9%). The predicted value and observed value of isophthalaldehdye (at Amax) are
shown in table 4 as expected.

Table 4: Summary the pre-extraction of PEl I Isophthalaldehyde from 1:1 to 16:1
(lsophthalaldehyde l.mu:= 194nm)
Predicted % relative
PEIIlsophthalaldehyde A=J...mn294nm amount of
Isophthalaldehyde
0:1
0.8868
100.0
1:1
0.3737
50.0
3:1
0.1781
25.0
5:1
0.1572
16.7
16:1
0.0565
5.9
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Observed 0/_
relative amount of
Isophthalaldehyde
100.0
42.1
20.1
17.7
6.3

Figure 5.5:

PEII Isophthalaldehyde in Variety Ratio Study by UV-Vis

(A)

PEl and Isophthalaldehyde

~

2.5
c 2
o

e.

1.5

~

0.5

~

1

o
Wavelength (nm)

(8)

PEUisophthalaldehyde Ratio from 1to 1to 16 to 1

~

2.5

c

2

o

e.

1.5
~ 1
.Q
0(

0.5

o
Wavelength (nm)

(A)UV-Vis Spectra ofpolyethylenimine and isophthalaldehyde. (B)
UV-Vis Spectra of polyethylenimine and isophthalaldehyde in a
different ratio from 1 to 1 up to 16 to 1

102

Figure 5.6 shows the UV-Vis spectra of the PElI isophthalaldehyde mixtures
before and after extraction by dichloromethane (CH2Ch). The UV-Vis spectra of PElI
isophthalaldehyde mixtures were recorded before and after extraction with
dichloromethane (DCM). The figure 5.6 spectra data shows that the isophthalaldehyde
alone is extracted into dichloromethane with 98.1 % efficiency. If isophthalaldehyde is
chemically incorporated into PEl, it cannot be extracted into dichloromethane. We
compared the UV-Vis spectra of the PEIIIsophthalaldehyde at ratio of 5: 1 and 16: 1
before and after the dichloromethane extraction. From the DCM extraction data, we
have observed the mixtures of PElI isophthalaldehyde at a ratio of 5 to I; the
isophthalaldehyde has 63.6% of remaining in the mixtures. The PElIisophthalaldehyde at
a ratio of 16 to I has 77.8% ofisophthalaldehyde remaining in the mixtures (Table 5).
From these results, it can be concluded that the PElIisophthalaldehyde volume ratio
of 16: I has smallest percentage of isophthalaldehyde removed from the mixture. The
higher ratio of PEl to isophthalaldehyde allows a greater proportion of the aldehyde to
form cross-links.
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Figure 5.6:

Polyetbylenimine and isopbtbalaldebyde extracted by
dichloromethane

~(b_)_ _ _ _ _ _ _ _ _ _ _ _ ~_,
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Po~ethyleninine (PEQ

Wavelength (nm)
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(d)

(c)

PElilso (16:1) before-after Extraction

PEIIIso (5:1) before-after Extraction

Wavelength (nm)

Wavelength (nm)

(a)UV spectrum of PEl (b) UV spectra ofisopbthalaldehyde before and after
extraction by CH2Ch (c) UV spectra of PEl and isophthalaldebyde mixture at
ratio of 5 to 1 before and after extraction by CH2Ch (d) UV spectra of PEl and
isophthalaldehyde mixture at ratio of 16 to 1 before and after extraction by
CH2Ch.
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Table 5: Summary UV-Vis absorption data: the isophthalaldehyde
extracted by dichloromethane in different ratios of PEl I
isophthalaldehyde.
I

A=A.max294nm

PEJlIsophthalaldehyde

PEl ( no
isophthalaldehyde)
• Isophthalaldehyde
Iso-Dichloromethane
(extraction)
PEJlIso=5: 1
PEJlIso=5: 1 (extraction)
PEJlIso=16: 1
PEJlIso=16 : l(extraction)

0
0.8868
0.0173
0.2824
0.1797
0.0967
0.0753

Iso : an abbreviation of isophthalaldehyde

o/. R
70

..
Abs (after extraction)
emalnlng = Abs (before extractIon)
. X t00 070/.
Abs : abbreviation of absorbance

Table 6: Percentage Remaining of Isophthalaldehyde: the mixture of PEl
and isophthalaldehyde after extraction by dichloromethane.

PEIJ
Isophthalaldehyde
Isophthalaldehyde
(no PEl)

I

%of
Isophthalaldehyde
Remainin2
1.9

PEI/Iso:::::: 5:1

63.6

PEI/lso = 16:1

77.8
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Table 6 shows the percentage of isophthalaldehyde remaining from 1.9% to 77.8
% with respect to the ratio ofPEJJIsophthalaldehyde from 0 to 16. In ratio 16 to 1 of
PEJJIsophthalaldehyde, the 77 .8% of isophthalaldehyde remaining indicates that after
removing any unbound or physically bound isophthalaldehyde, there is still 77.8% with
covalent chemical bonding to form the cross-linking within the PEl molecules. These
results are strongly supportive that PEl cross-linking reaction is a covalent, chemical
cross-linking reaction.

5.2 Light Scattering Analysis of Aggregation Behavior
Polyethylenimine particle size was performed by using QELS light scattering
techniques. The PEl molecular hydrodynamic radius as a function of concentration was
determined by QELS light scattering analysis.

Table 7 shows how with increasing

concentration of PEl, we observed a decrease of the macromolecules' hydrodynamic
radii. This indicated that the molecular repulsion force plays a role with shortening
intermolecular distance as the cationic polymers are forced to be closer together; they
shrink slightly from these ionic repulsions.

Table 7:

Polyethylenimine (in water) Hydrodynamic Radius as a function of the
concentration

Polyethylenimine(M)
0.1
0.4
0.6
1.0
1.2
1.4
1.8

Hydrodynamic Radius (nm)
4.88
4.76
4.76
4.68
4.66
4.54
4.51
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Figure 5.7: Polyethylenimine (in water) Radius in different Concentration
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Figure 5.7 shows the PEl radius (Y axis) as function of the concentration ofthe
polyethylenimine (X axis). The results showed a slightly decrease in the
polyethylenimine radius with increasing PEl concentration. PEl molecules, as
polycationic polymers, are far apart from each other in very dilute solution. The PEl
molecules are not repelled much by other molecules due to the long range distance. As
the PEl concentration goes up, the molecules are closer to each other. The molecular
charges repel, and as this force increase the radius of the molecules decreases.

5.2.1

Cross-Linking Hydrodynamic Radius Measurement by QELS
The molecular radius (r) of cross-linked PEl hydrodynamic radius was also

investigated by light scattering analysis. The experiment was designed by studying the
cross-linking reaction with two PEl concentrations (0.1 M and 1.8 M) titrated into a fixed
concentration of the isophthalaldehyde (0.004 M).
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From Table 8, we have observed the molecular radius of the cross-linked PEl
decreasing from 5.82 nm to 3.89 nm as isophthalaldehyde solution (up to 1.8 mL) was
added into the low concentration ofPEI (OJ M). This observation indicates that the
cross-linking reaction was intra-molecular in low PEl concentration. At low
concentration, once the isophthalaldehyde has reacted with one PEl molecule, it is much
more likely to react again with a free NH2 from that same molecule. Collisions between
the widely dispersed polymer chains are infrequent, so reaction of the second aldehyde
with a different PEl molecule to from an intermolecular cross-link is unlikely.
The aliquot volumes of the isophthalaldehyde (0.004 M) solutions were added into
higher concentration of PEl (1.8 M) solution. Table 9 shows a similar reduced radius
pattern (as seen in table 8) with addition of isophthalaldehyde, but the slope is much
shallow in 1.8 M PEl. When adding an increasing amount of isophthalaldehyde into the
PEl solution, the PEl molecular particle size decreased only slightly. This observation
indicated that the PEl and isophthalaldehyde cross-linking reaction is still an intra
molecular reaction (compact in size). The reduced slope occurs since the number of
cross-links in each PEl molecule is smaller. No increase in radius - as would occur from
intermolecular cross-linking - was observed.
Our lH NMR, UV-Vis extraction, and light scattering studies results are strongly
support that isophthalaldehyde acts as a cross-linker for PEl. The cross-linking reaction
is primarily an intra-molecular cross-linking with PEl concentration up to 1.8M.

In conclusion, whether inter or intra molecular cross-linking reaction occurred
depends on the concentration of PEl. At very high concentrations of PEl (reactions in
bulk or pure PEl), we have observed the aggregation and insolubilization behavior which
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indicated the inter-molecular cross-linking between the PEl molecules. However, in a
low concentration of PEl, the cross-linking reaction is intra-molecules cross-links.
The cross-linking experiments have suggest that the idea ofusing PEl as an imprinting
medium for DNA seems viable- PEl is known to bind DNA and can be cross-linked with
isophthalaldehyde.

Table 8:

Low concentration of PEl (0.1 M) Titrated with Isophthalaldehyde
(0.004M) in Phosphate Buffer pH7.0

Isophthalaldehyde
added(mL)

Radius (nm)

Normalized Radius

0.0
0.1
0.3
0.5
0.8
1.0
1.5
1.8

5.82
5.62
5.40
5.13
5.03
4.71
4.45
3.89

1.00
0.97
0.93
0.88
0.86
0.81
0.76
0.66
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Figure 5.8:

Isophthalaldehyde (0.004 M) Titrated into Low Concentration of
Polyethylenimine (0.1 M)
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Table 9: High Concentration of PEl (1.8 M) Titrated with Isophthalaldehyde
(0.004 M) (in phosphate buffer, pH 7.0)

Isophthalaldehyde

ImLl
0.0
0.2
0.6
0.8
1.0
1.5
2.0
3.0
4.0

Hydrodynamic Radius
(nm)

Normalized Radius

5.64
5.53
5.37
4.86
4.62
4.53
4.33
4.16
4.06

1.00
0.98
0.95
0.86
0.82
0.80
0.77
0.74
0.72
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Figure 5.9: Isophthalaldehyde (0.004 M) Titrated into 1.8 M PEl (both prepared in
Phosphate Buffer Solution at pH 7.0)
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5.3 Binding Study of Polyethylenimine I Quadruplex DNA
Figure 5.10 shows the CD spectrum ofG-quadruplex (T4G4) DNA. This CD
spectrum displayed a positive maximum peak at near 265 nm and a negative minimum
peak at 240 nm. These are the characteristic features of the parallel G-quadruplex DNA
structure.

206

The quadruplex (T4G4) DNA has been reported to have a parallel G

qUadruplex structure.
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Figure 5.10:

CD Spectrum of Quadruplex T4G4 DNA (parallel)
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Figure 5.11 shows the CD spectrum of the polyethylenimine. CD is characteristic of
the molecular and environmental asymmetrical effects. Because PEls has no significant
CD signal within the UV region, we are not able to see any absorptivity in spectra. The
CD spectrum of the PEl is simply showing the noise level.

Figure 5.11: CD Spectrum of the Polyethylenimine

CD Spectrum of Polyethylenimine
0
_2220

£

320

-4

~

-6

==
.1:IiI

-8

;1:1.

270

-10
·12

-PO

-14

Wavelength (om)

112

5.3.1 Circular Dichroism (CD) Titration Experiments

In this work, we have used CD spectroscopy to monitor the quadruplex T4G4 DNA
conformational changes in PEIIT4G4 quadruplex DNA complex solutions. A pre-mixed
quadruplex DNA with PEl at a tenfold excess solution were prepared for use in our first
titration study. DNA is included in the titrating solution to maintain a constant DNA
concentration (and therefore a constant CD signal). PEl has no CD signal within the UV
region. Hence, the observed signals recorded only from the quadruplex DNA molecules.
Figure 5.12 shows the titration experiment, where the pre-mixed solution of lOX
PEIJ quadruplex DNA was titrated into G-quadruplex DNA (250 ~l) solution. The
titration began from the pre-mixed sample (PEIJquadruplex DNA) by additionally added
I ~L into G-quadruplex T 4G4 solution. As we observed from the CD spectra, quadruplex
DNA conformation was changed by adding more PEl (a pre-mixed lOX PEIJDNA
solution) into DNA solution. We observed a change in the positive maximum peak near

265 nm, gradually changing to a negative peak near 285 nm. The CD spectra show that
quadruplex DNA maximum positive peak in the vicinity of 265-270 nm (parallel), then
gradually decreased in intensity when more pre-mixed solution was added to the
quadruplex DNA solution.
From the observed changes in the CD spectra, there are a few possible
interpretations: PEl might disrupt the quadruplexes (T404) DNA conformations
completely to single strand DNA or could change the conformation from a parallel
orientation to different conformation - antiparallel, mixed, or some other transitional
structure.
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Figure 5.12: lOX PEIIQuadruplex DNA pre-mixed Solution with 1 ilL each
addition titrated into Quadruplex T4G4 DNA Solution (250 ilL)

DNA (2S0ul),PEUDNA 1ul
DNA(250ul). PEIIDNA 3 ul

14,,-------------,

.--.---~------.,

....

..

'

\.~.

,.........

1

o

·21--.._ _ _ _ _ _ _ _ _----1
Waveleng1l! (MIl

DNA(250ul). PEIIOHA 8 ul

OHAI25Ou1),PEUONA Bul

-3

..01

-s
;

.a
-7

-8
·8
"0

-10 " - - - - - - - - " - - - - - - - '

.L......-_-'-~

_ _- ' - " " ' -_ _- '

In order to gain further insight into the conformational changes, we have
conducted additional titration profiles. Figure 5.13 shows the profile of the pre-mixed
DNA/lOX PEl titrated into 250

!!L G-quadruplex DNA.

The CD spectra show that

quadruplex DNA maximum positive peak in the vicinity of 265-270 nm (parallel), then
gradually decreased in intensity when more pre-mixed solution was added to the
quadruplex DNA solution.
Table 10 summarizes the overall data from the quadruplex DNA and PEl titration.
When the (T4G4),JPEI ratio is at 25, the positive peak - 265-270 nm showed a slightly
change in conformation, compared with the quadruplex DNA alone. It was noted that the
quadruplex DNA maximum peak decreased and gradually turned negative when higher

114

amounts of the pre-mixed DNAIPEI solution were added to the quadruplex DNA
solution. These results indicated that the cationic polymer PEl might disrupt the
quadruplex (T40 4) structure or change it in a complex manner. However, fully
understanding of the (T404)4 DNA and PEl interaction remained a challenge.

Figure 5.13:

Pre-mixed (T..G..).. IPEI Titrated into Quadruplex DNA (250pL)

DNA (25() pi) Titrated witJa PEIIQ-DNA Ipl Eacla Additioa
2
0
-2

H
~

~

=
:=
::is

-4
-6

.

-8

• llIlfD.O.DlQ
• l~PD.Q-DlQ
• l::lj&lPD.Q-DlQ

,~

-10

~ ~m.q.DIQ

..

•

• 12

.. lfidl'EtODlQ
~~

.2QdnI.QDlQ

-14
-16
200

220

240

260

280

\V aveiealtll(Dm)

115

300

320

Table 10: Parallel Quadruplex DNA (T4G4) (250"L) Titrated with Pre-Mixed
(PEl/lOx DNA), A Positive Maximum Peak in the Vicinity of 265-270 nm
Added Pre-Mix
PEl/lOx DNA
solution (JlL )

Overall ratio
DNAIPEl

Comment

I

2511

3

-811

8

-3/1

Positive peak -265 nm ,12 mdeg,
showed little change in confirmation
Positive peak -265 nm, now only 7
mdeg
Positive peak -265 nm is lost, -I mdeg

10

5/2

Negative peak -265 nm ,-2 mdeg

20

-111

Negative peak -265 nm,
-4mdeg

Figure 5.14 shows stability of the (T4G4) quadruplex DNA! PEl complex solution.
Quadruplex DNA solutions with added PEl solution were scanned by CD at initial, day I
and day 7. The CD spectra of quadruplex DNA / PEl polyplex solutions showed only
small changes from day 0 to day 7. This result suggested that the quadruplex (T4G4)
DNAlPEI conformation is relatively stable at 4 °c condition for up to 7 days.
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Figure 5.14:

Quadruplex (T4G4) DNAIPEI Solution Stability
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It had been our original intention to imprint PEl with the quadruplex DNA by

cross-linking with isophthalaldehyde. The CD data shown above however, throws the
viability of this approach into question. When mixed with PEl; the quadruplex DNA
might change or disrupt the conformation and no longer be a parallel quadruplex
structure (from the CD data). These results brought an uncertainty to our initial goal.
We decided to study other polymers to find if a better candidate existed for our model of
the imprinting with T40 4 quadruplex DNA.
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5.4

Porphyrinl Quadruplex T4G4 DNA I Polymers Interaction Study by UV-Vis
Porphyrins have a "ring of rings" structure of four pyrrole units, and are aromatic

with an 18 1t-electron scaffold which allow for the ability to absorb visible light.
Porphyrins are also known to be able to associate or intercalate with the anionic
phosphate backbone ofDNA. 28o ,325
We investigated the interaction of polycationic and neutral polymers with a
quadruplex (T4G4) DNA/ porphyrin complex; this acted as a screen for other polymers
that will bind DNA.

In screening the polymers, we have observed that the porphyrin

Soret band shifts from 422 nm to 433 nm when quadruplex DNA is added into the
porphyrin. On addition ofpolymer, the Soret band might shift back to 422 nm, as a result
ofdissociation of the porphyrin from the DNA; or the Soret band might remain at 433 nm
indicating an intact porphyrin-DNA complex.
Figure 5.15 shows the UV spectra ofpolyethylenimine in the presence of the
porphyrin-quadruplex DNA complex. When quadruplex DNA was added into
porphyrin, the porphyrin maximum peak shifted to 433 nm, evidence of the formation of
the DNA/porphyrin complex. After adding the polyethylenimine to the porphyrin-DNA
complex, the porphyrin maximum peak shifted back to 422 nm. Figure 5.16 shows the
interaction of the cross-linked PEl with the porphyrin! DNA complex, where the cross
linked PEl demonstrated the same binding behavior as the non-cross-linked PEl
Poly (4-vinyl-I-methylpyridinium bromide), an ionic polymer, also showed the
same binding profile as PEl when porphyrin! quadruplex DNA complex was added
(figure 5.17). Polyethylene glycol (pEG) is a nonionic neutral polymer which is often
used as protein stabilizing agent. Figure 5.18 shows the polyethylene glycol (PEG) with
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the porphyrin! T4G4 quadruplex DNA complex.

The UV-Vis spectra have shown the

porphyrin peak remains at 433 nm after addition of the PEG. This result might support
hypothesis ofthe binding behavior as: (1) non-binding of the PEG and quadruplex DNA
or (2) binding without the disruption of the quadruplex DNA with PEG.
When poly (N-vinylpyrrolidone)was added to the porphyrin / quadruplex DNA complex,
the absorption maximum remained at 433 nm which might indicate an intact of
porphyrin-DNA complex (figure 5.19). Figure 5.20 shows poly (4-vinylpyridine Noxide) with porphyrin-quadruplex DNA complex. When poly (4-vinylpyridine N-oxide)
interacted with porphyrin! quadruplex DNA complex, the maximum peak remained at
433nm after polymers (PVNO) were added.

Figure 5.15: Polyethylenimine interaction with porphyrin-quadruplex
T4G4 DNA complex

Porphyrio/QuadnJplex T..G.. DNAlPEI

0.6

-+- Porphyrin

0.5
0.4
0.3

-

PorphyrinlQuadruplex
DNA
.-...-Porphyrin/Q-DNAIPEI

0.2

0.1 _ _-;-'-jIII'"

....

o~~==~~--~~

350

370

390

410

430

Wavelength (nm)

119

450

470

Figure 5.16: Cross-linked polyethylenimine interaction with porphyrin
quadruplex T4G4 DNA complex
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Figure 5.17: Poly (4-vinyl-1-Methylpyridinium Bromide) interaction
with PorphyrinlQuadruplex T 4G4 DNA Complex
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Figure 5.18:

Polyethylene glycol (pEG) interaction with
PorphyrinlQuadruplex T.G. DNA Complex
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Figure 5.19:

Poly (N-vinylpyrrolidone) Interaction with porphyrin
quadruplex T.G.DNA complex
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Figure 5.20: Poly (4-vinylpyridine N-oxide) interaction with
porphyrin-quadruplex DNA Complex
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Table 11 summarizes the screening of neutral and cationic polymers. The UV-Vis

I

spectra showed that the maximum peak of the porphyrin will shift back to 422 nm after

I

adding cationic polymers into the porphyrin and quadruplex DNA complex. When

j

ij

neutral polymers were added to the porphyrin and DNA complex, the porphyrin

1

maximum peak remained at 433 nm.

I
iI
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Table 11: Porphyrin Probe Screening of Candidate Polymers

Polymer
C= Cationic
N=Neutral

Poly(2-vinyl pyridine) (C)

PEl (C)
Poly(allylamine)
20%wt(C)

Porphyrin
(nm)

Porphyrin A"..,. after Added
DNA (nm)

Porphyrin Amax after Added
DNA and polymer (nm)

A".,.,
422

433

422

422

433

422

422

433

422

422

433

422

422

433

422

422

433

422

422

433

422

422

433

422

422

433

433

422

433

433

422

433

433

Poly(L-lysine) (C)
Metafectene Easy(CJ
Metafectene Pro (C)
Poly(4-vinly-l
methylpyridinium
bromide) (C)
Poly(L-omithine) HCL
(C)
Poly{N- vinylpyrrolidon)
(N)

Ploy(4-vinylpyridine
N-oxide) (N)
PEG (N)

These screening results show that neutral polymers might be considerable
candidates to further study for the binding of the quadruplex DNA with minimal
disruption. We have assumed that neural polymer might bind to quadruplex DNA
without disrupting the quadruplex structure based on the UV-Vis data. But, the porphyrin

Arnax peak remaining at 433nm might also lead to a different answer: that there is no
interaction of these neutral polymers with quadruplex DNA (no binding). To determine
if the neutral polymers are binding to DNA, we have further investigated the polymer and
DNA interaction by 2D NMR techniques.

123

5.5

31

31p

P NMR Polymer - Quadruplex DNA Binding Study

NMR is a powerful tool that has been applied to a wide variety of studies.

31p

is a

spin!h nuclei and has 100% natural abundance. All phosphorus species within a
compound can potentially be detected by NMR spectroscopy. Due to the overlap and
interference of the proton chemical shifts of DNA and poly(4-vinylpyridine-N-oxide) in
the aromatic region, we cannot use I H NMR diffusion experiments to study the mixture
of the (T4G4) quadruplex DNA with poly (4-vinylpyridine-N-oxide). The 31p NMR
diffusion experiment is therefore a preferred method to examine the interaction of the
quadruplex DNA and PVNO polymer.
In figure 5.21,

31p NMR spectra

show the binding interaction of the quadruplex

DNA with the following polymers: poly(N-vinylpyrrolidone), poly(4-vinylpyridine N
oxide) and polyethylenimine. The spectrum of polyethylenimine was observed to shift to
the left (down field) compared with the free (T4G4) quadruplex DNA. It is apparent that
PEl has bound to quadruplex DNA from the change in the chemical shift. In figure 5.21,
comparing with the free T4G4 quadruplex DNA pattern, we also observed no shift in peak
maximum for the poly(N-vinylpyrrolidone) and poly(4-vinylpyridine N-oxide). This
might indicate that there is a no binding relationship between the polymers and
quadruplex DNA. However, other researchers' findings reported that poly(N
vinylpyrrolidone) is known to interact with the quadruplex DNA.326

It might therefore

be more appropriate to suggested that the PEl has a stronger binding interaction than PVP
and PVNO, one that is centered on association of the negative phosphates of DNA and
positive ammonium ions of PEl. Another possibility is that PVP and PVNO do not
interact with DNA phosphate backbone, but the interacting sites may close to the base.
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This would have a maximum effect on the electron density and shielding at the P nuclei,
resulting in a change in chemical shift. In comparing with the free (T4G4) quadruplex
DNA, the PVNO and PNVP have shown the minor changes in contour line of spectra;
however, there is still not sufficient evident for assessing whether these neutral polymer
are binding with (T4G4) quadruplex DNA or not.
In order to assess whether the poly(N-vinylpyrrolidone) would bind to quadruplex
DNA or not, we examined the interaction by increasing the polymer concentration in the
NMR. In figure 5.22, we have observed that the peak maximum of the
poly(N-vinylpyrrolidone) shifted downfield (to the left side) relative to the previous
experiment (figure 5.21). This result confirmed that the poly(N-vinylpyrrolidone) is
bound to (T4G4) quadruplex DNA; in addition, this result also suggested that the poly(N
vinylpyrrolidone) has a stronger binding interaction with quadruplex DNA than poly (4
vinylpyridine N -oxide).

I
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Figure 5.21:

P NMR Spectra of (TTTTGGGG)4, free and in the presence of
Poly(4-vinylpyridine N- oxide), Polyethylenimine and Poly (N
vinylpyrrolidone)
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Figure 5.22:

P NMR Spectra of (TTTTGGGG)4, and with Poly(4-vinylpyridine
N-Oxide), Polyethylenimine and Poly(N-vinylpyrrolidone) with
increased concentration of Poly(N-vinylpyrrolidone) and Poly(4
vinylpyridine-N-Oxide)
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5.6 DOSY: Diffusion NMR Experiments
Diffusion-Ordered (DOSY) NMR spectroscopy provides a way to separate the
spectra of different compounds in a mixture based on the different diffusion coefficients.

noSy applies the diffusion analysis through the pulse-field gradient NMR methods. In
noSy, the spectra are displayed in a 2D plot with chemical shift on one axis and the
diffusion coefficient (often in a logarithmic scale) on the other. 326 Compounds with the
same diffusion coefficient will then appear correlated on the diffusion axis. Two
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molecular species with different diffusion coefficients when measured alone show the
different diffusion coefficients. If, when mixed together, they appear at the same
diffusion coefficient, then it is reasonable to assume that the two molecules are bound
into a single complex with a single diffusion coefficient.
In this pseudo two dimensional NMR technique, one dimension (X axis)
represents typical chemical shift information

eH or

31

P (ppm» and the second dimension

(Y-axis) distinguishes species by diffusion coefficient represent by the logarithm of
diffusion constant (Log D). The size of the polymer is often much larger than (T4G4)
quadruplex DNA (-10 kD) because the molecular weight of the polymer is much higher
than (T4G4) quadruplex DNA. As a result, polymer displays a smaller diffusion
coefficient and much broader peaks than T4G4 DNA does. In order to obtain stronger and
more sensitive signal from diffusion NMR, we will need to monitor the DNA peaks
rather than the polymer peaks. When DNA binds to polymer; the polymer diffusion will
not change much - the diffusion rate will be dominated by the large polymer component.
The DNA, on the other hand, will experience larger changes when it binds to polymer
and diffuses the same as the polymer. In these diffusion experiments, we will examine the
aromatic peaks from the quadruplex DNA portions. Figure 5.23 shows the DOSY
diffusion experiment for (T4G4) quadruplex DNA and poly (N-vinylpyrrolidone) (PVP) at
the ratio of 1 to I, 1 to 5 and 1 to 10, respectively.
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Figure 5.23: DOSY NMR Experiment Study Binding Relationship ofQuadruplex
(T4G4) DNA alone (black) and with Poly(N-vinylpyrrolidone) (PVP) at
the ratio of 1:1 (blue), 1:5 (red) and 1:10 (green)
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In figure 5.23, the Y-axis represents ofthe logarithm ofdiffusion coefficient (Log D

(m2 S·l». So spectra which occur nearer the top have slower diffusion. The X-axis
represents 1H chemical shift (ppm). The different colors represent different ratios ofthe
polymer with (T404) quadruplex DNA. The black color indicates (T404) quadruplex
DNA only. The blue color, red, and green color represent the quadruplex (T404)1 PVP at
ratio of 1 to 1, I to 5 and I to 10, respectively. We have observed that the DNA alone
(black) and DNA:PVP 1 : 1 (blue )spectra are almost superimposed, which indicated the
mixture of the quadruplex (T404) and PVP (1: I) and DNA alone might have nearly
identical diffusion coefficients. This can be explained by the fact that polymer and
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quadruplex DNA at I to I ratio did not have much effect on the diffusion (weak binding).
On the other hand quadruplex (T4G4) and PVP at I to10 ratio gave multiple diffusion
rates for small fragment species - faster diffusing than the intact quadruplex.

These

faster diffusing species might indicate that the Poly(N-vinylpyrrolidone) (PVP) begins to
disrupt the quadruplex (T4G4) DNA into single strands or fragments at this high
concentration. As we can see in the diffusion pattern, the quadruplex (T4G4) and PVP at I
to 5 ratio (red color) showed a slowing down of the diffusion, which indicates the
polymer (PVP) was bound to (T4G4) quadruplex DNA. The diffusion analysis shows that
interaction ofPVP and DNA is somewhat complex, with variability based on
concentration.

Figure 5.24:

Diffusion DOSY Experiment of Quadruplex T 4G 4 alone (black)
and with Poly (vinylpyridine N-Oxide) (PVNO) (red)

31p
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Figure 5.24 shows the diffusion pattern of the 31p DOSY NMR showing the
binding interaction of the quadruplex (T4G4) DNA and poly(4-vinylpyridine N-oxide)
(PVNO). In the simple chemical shift experiment, we did not see any significant change
with PVNO as compared to the free quadruplex DNA. We had some doubts about the
interaction ofPVNO with quadruplex DNA. Then we carried out a DOSY experiment for
the further investigation. The overlap of the DNA and PVNO IH spectra required the use
of 31 P NMR. The Y-axis represent logarithm of diffusion coefficient (Log D) and X-axis
represents 31 P chemical shifts (ppm). The color codes again represent combination of
the polymer PVNO and quadruplex DNA. The black color represents the quadruplex
(T4G4) alone. The red color represents quadruplex (T4G4) DNA and PVNO at a ratio of I
to 5.

Quadruplex DNA log D is about -9.5, corresponding to a diffusion coefficient of

3.2xlO- lO• For DNA with PVNO at a I to 5 ratio, the log D is about -9.8 which
correspond to a diffusion coefficient of 1.6 X 10-10, a factor of2 slower. We have
observed the similar diffusion pattern for PVNO and quadruplex DNA as PVP and
quadruplex (T4G4). However, the diffusion coefficient (D= (kT)/ j) is related to friction
coefficient (f= 6 1C 11 RH)' The effect of the viscosity (11) in solution will affect the
diffusion constant. When polymer binds to DNA, the slight decrease in D might be due
to the viscosity change in solution rather than the real binding interaction of the polymer
and quadruplex DNA. We conducted another experiment to investigate the polymer
viscosity effect in PVNO polymer.
In this experiment, we took the viscosity condition into account and examined the
binding relationship by 3Ip_DOSY techniques. A PEG concentration was prepared which
had the same viscosity as the PVNO solution. The sample preparation was described in
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the methods section. Figure 5.25 shows 31 p DOSY spectra of quadruplex DNA, mixture

concentration ratios of the polyethylene glycol (PEG) / quadruplex (T4G4) DNA, and the
PVNO / (T4G4)4 DNA are both 5 to 1. The red and blue color code are symbolized the
(PEG) / quadruplex (T4G4) and PVNO / (T4G4)4, respectively. The black color represents
the quadruplex (T4G4) DNA alone.

Figure 5.25:

P DOSY Experiment for Quadruplex DNA, (T4G4)4/ PVNO at 1:5
ratio and quadruplex (T4G4) !PEG at 1 to 5 ratio
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As observed in the spectra, the quadruplex (T4G4) alone displayed the log D about
-9.6 which is corresponding to the diffusion coefficient of3.98 xlO- 9 • The mixture of the
PVNO and quadruplex DNA had log D about -9.8. The corresponding diffusion
coefficient for PVNOI (T4G4)4 complexes is 1.6 x 10-10 The PEG I quadruplex DNA
solution has a diffusion coefficient of 5.0 x 10- 11 (logD is -10.3). The spectra of the PEGI
(T4G4)4 displayed a broadened diffusion profile which illustrated the distribution of
environments for DNA mobility when increased viscosity is the main contributing factor.
The PEG is a neutral polymer which has been found to have no binding affinity with the
quadruplex DNA but has the molecular crowding effect for the stabilization of the
DNA. 344 We have observed that the mixture of the PVNOI (T4G4)4 spectra have a sharp,
narrow diffusion profile, but the reduction in diffusion coefficient is slight.

We note

that the diffusion coefficient of PVNOI quadruplex DNA is only about 1.6 times higher
than the quadruplex DNA alone, whereas a larger change would be expected for strong
binding with the PVNO. The difference in diffusion profile with the viscosity agent PEG
suggests a different mode of interaction than PEG. The nature of the association of DNA
with PVNO remains ambiguous.
Figure 5.26 shows the mixture of the PEl and (T4G4) quadruplex DNA in IH
DOSY Experiment. The (T4G4) quadruplex DNA in the experiment is used as the
reference for the comparison for the PEl. The Y-axis represent logarithm of diffusion
coefficient (Log D). The X-axis represents 1 H chemical shifts (ppm). The blue color
code represented the combination of the polymer PEl and quadruplex DNA at a ratio of 5

tol. The black color represents the (T4G4) quadruplex DNA alone. The quadruplex (T4G4)
displayed the log D about -9.7 which is corresponding to diffusion constant at 5.01 xlO·9•
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As observed in the spectra, the PEl and DNA at 5 to 1 ratio, the log D is about -10.3. The
corresponding diffusion coefficient for PEl! (T4G4)4 complexes is 1.99 x 10-10• PEl with
quadruplex DNA showed a lower diffusion coefficient and a shifted in the spectra. This
data suggested that the polymer (pEl) bound to quadruplex DNA.

Figure 5.26: IH DOSY Experiment for Quadruplex DNA (f..G..) alone (black) and
DNAIPEI at Ratio of 1:5 (blue)
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5.7

PEl Induced Conformational Changes in Quadruplex DNA (T4G 4)4: 2D
NOESY NMR and CD Experiments

Figure 5.27 shows the 2D NOESY spectrum of the parallel G-quadruplex T4G4.
The G-quadruplex T4G4 NOESY spectrum has several clear regions. The resonances
from 10.5-12 ppm are denoted as the imino proton resonances (HI of the guanines).
There are also amino protons from 8.0 - 10.5 ppm, aromatic protons from 6.8 -8.0 ppm,
sugar protons from 4.0 - 6.5 ppm, and thymine methyl protons from 1.4-2.0 ppm.
The imino protons (10-12 ppm) are characteristic of guanine imino-H8 cross-peaks for Gtetrads. The cross-peaks between the imino protons, between the imino and amino
protons, and between the aromatic and sugar protons are characteristic of the G
quadruplex structures.
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Figure 5.27: A 2D NOESY spectrum of G-quadruplex T 4G4 Parallel Structure
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Figure 5.28 shows G-quadruplex (T4G4) DNA mixed with PEl at a 1 tol molar
ratio. In this experiment, the spectra recorded did not show the proton resonances peaks
in the region of the 10 to 12 ppm, which typically indicated the imino proton resonances.
The amino peaks from 8.5 - 10 ppm are also absent. These unresolved peaks may appear
as broadened signals as a result of the NMR time scale detection limit and therefore
invisible in this NMR spectrum. The signals may be broadened due to the
conformational exchange between structures. These results indicated that the protons
might undergo an intermediate exchange. However, the cross-peaks and diagonal peaks
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could clearly be seen from 5.5 to 8.5 ppm, the aromatic and amino proton chemical shift
region. These cross-peaks are not necessarily determinative of any quadruplex structure.
This result suggest that the G-quadruplex (T4G4) DNA and PEl at I tol ratio might have
weak binding or be in eqUilibrium between multiple structures.

Figure 5.28: 2D NOESY spectrum of G-quadruplex (T4G4) DNA and PEl at 1 t01
Molar Ratio
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Figure 5.29 shows the 2D NOESY results for T4G4 quadruplex DNA and PEl mixed
at a 1 to 5 molar ratio. Here two peaks can be observed in the diagonal region near 11.0
ppm, where the guanine imino proton resonances occur (10.8-11.6 ppm). While no
amino peaks appear on the diagonal, imino-amino cross peaks are observed, which
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suggests that the G-quadruplex structure is intact. The NOESY spectrum shows other
changes which are suggestive of a structural transition, further evidenced by the CD data
provided below.

Figure 5.29: 2D NOESY Spectrum of G-quadruplex T4G4DNA and PEl at 1 to 5
Molar Ratio
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Figure 5.30 shows the imino-imino and imino-amino regions of the NOESY
spectra for parallel T4G4 quadruplex DNA (A) and T4G4 DNA with PEl 1:5 (B).
Comparison of the imino regions of the native, parallel T4G4 quadruplex and the T4G4
quadruplex mixed with PEl 1:5 shows a reduction in the number of peaks in the presence
ofPEI. The parallel T4G4 shows at least 8 imino peaks, and possible as many as 12, with
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multiple cross peaks. The presence of more than 4 imino peaks shows that there are
some differences within the individual tetrads of the parallel quadruplex. In the presence
of PEl, only 2 imino peaks are seen, with one cross peak between them. There are
several possible explanations for the reduced number ofpeaks: some of the peaks may be
broadened and undetectable, or a change in conformation may have reduced the number
of environments. The simplest changes in conformation would be the reversal of one or
two strands to produce a mixed (3:1) or antiparallel quadruplex. However, even the most
symmetric antiparallel quadruplex from T404 would have at least 4 different imino
environments. For true assignments, isotopically labeled guanines are typically usedthese were outside the scope of our experiments.

Figure 5.30: Imino-imino and Imino-amino regions of the NOESY spectra for
parallel T4G4 quadruplex DNA (A) and T4G4 quadruplex DNA with

PEl 1:5 (8)
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B
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Figure 5.31 shows NOESY spectra of aromatic H61H8 to sugar HI' region for
parallel T4G4 quadruplex DNA (A) and T4G4 quadruplex DNA with PEl at 1:5 ration (B).
One of the key areas of the NOESY spectrum for conformational analysis is that the
aromatic (H6/H8) to sugar (HI') cross-peaks regions are showed between 7.0 - 8.0 and
5.4 - 6.6 ppm which enabled us to assign all aromatic and anomeric protons. The
resonance of a thymine methyl group was assigned through strong intra-residual cross
peak with intra-residual H6 proton in 2D NOESY spectra. The conformation of the base
with relation to the backbone can be syn or anti. Moving from 5' to 3', there are four
possible arrangements with different cross-peak results. Anti to anti gives 3 strong cross
peaks, syn to anti gives 3 strong and one weak cross peaks, anti to syn gives two strong
cross peaks, and syn to syn gives two strong and one weak cross peak. In general, the
presence of syn bases reduces the number of cross peaks. The number of cross peaks is
in fact greatly reduced in the presence of PEl. A few are unchanged - for example
between the aromatic peak at 7.8 and the sugar at 6.1 ppm. There are a few new ones 
for example 7.5 to 6.25 ppm. But many have disappeared. This could be a result of
increased syn conformations: the parallel T4G4 is expected to be all anti, while a change
to the 3: 1 or anti parallel structures would require some syn conformations. However,
without the precise assignments from isotopic labeling, we cannot make an exact
structural determination.
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Figure 5.31: Aromatic H61H8 to sugar HI' region of the NOESY spectra for
parallel T4G4 quadruplex DNA (A) and T4G4 quadruplex DNA with
PEl 1:5 (B)

B

A

, ,.

...

II

!ua~

I

•• t

;

t
I•

i

,

r

0

I..
."

u'i
i

--..---.---..-~~."

.

,I
0

tv

•

,Ito•

~

Figure 5.32 shows aromatic H61H8 to thymine methyl region of the NOESY spectra
for parallel T4G4 quadruplex DNA. Parallel T4G4 quadruplex DNA alone showed in part
A. The T4G4 DNA with PEI in 1 to 5 ratios showed in part B. We have observed the
Finally, the methyl groups of the T tails can be used. In the parallel structure, all of the
tails are together, and more cross-peaks are expected as compared to an antiparallel
arrangement. In fact, when in the presence of PEl, the number ofcross peaks between
the thymine methyl region (1.4 2.0 ppm) and the aromatic region (6.6 - 8.0 ppm) is
reduced. Once again, this reduction could be due to broadening of resonances or to a
structural transition. In summary, the NOESY spectra support a structural change
induced by PEl but are not definitive.
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Figure 5.32: Aromatic H61H8 to thymine methyl region of the NOESY spectra for
parallel T4G4 quadruplex DNA (A) and T4G4 DNA with PEl 1:5 (B)
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5.8 Circular Dichroism Experiment of the PEl and quadruplex (T4G4)DNA:
Structural Transition Investigation.

The NOE results caused us to re-examine our CD data, and acquire some new data
as well. Samples were made up identical to those used for NMR study - quadruplex
T4G4 DNA, quadruple x T4G4 with PEl 1: 1, and quadruplex T4G4 with PEl 1:5. Figure
5.33 shows the CD spectra of the quadruplex (T4G4) DNA alone and with PEl at 1 to 1
and 1 to 5 molar ratio. The CD measurements were taken immediately after mixing,
without allowing any equilibration time. In typical G-quadruplex parallel structure,
guanines all have the same anti glycosidic conformation which exhibits a positive peak at
260 nm and small negative peak at 240 nm. The CD spectra ofthe PEIIquadruplex DNA
at I to I and 5 to 1 molar ratio are showed a positive peak near 260nm and a negative
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peak near 240 run in all three sample, which are consistent with the typical parallel
stranded G-quadruplex conformation. The CD spectra all appear similar; which indicated
no conformational changes at the initial time point.

Figure 5.33: CD Spectra of the Quadruplex DNA alone and with PEl at 1 to 1 and
1 to 5 Molar Ratios at the initial Time Point
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Figure 5.34 shows the CD spectra of the PEl! T4G4 quadruplex DNA mixture (5 to
1 molar ratio in potassium buffer) at different times following addition of PEl to the
DNA. We have observed the CD spectrum changing within four hours after addition.
The two and half hours spectra showed a negative peak near 260 run. A negative peak at
260 run has been associated with an antiparallel structure in the presence ofNa+ ions. 327
Our T4G4 quadruplex DNA without adding the polymer is a parallel quadruplex
conformation. In typical CD spectra of G-quadruplex structures, parallel·stranded
guanines exhibit a positive peak at 260 nm and a small negative peak at 240 nm.
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In

an antiparallel-stranded of G-quadruplex conformation, guanines have alternating anti
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and syn glycosidic confonnation along each DNA strand, which generates a positive peak
at 290 nm, a negative at 260 nm and a very small negative peak at 240 nm.
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The time profile of the PEIIquadruplex DNA mixture (5:1) CD spectra is puzzling,
especially after four hours, shows that is neither purely parallel or antiparalle1 - a mixed
or hybrid confonnation. We tried to shed light on this structural transition of quadruplex
DNA induced by PEL In a search of the literature, we have found that Smargiasso et al
has reported the mixed/hybrid of quadruplex DNA in different cations (K+, Na+ and
N~ J. 330 The hybrid-quadruplexes DNA are the mixtures of parallel and anti-parallel

strands in orientation. The DNA in the presence of potassium and ammonium cations
mostly existed as mixtures of parallel and anti-parallel orientation. The pure anti-parallel
structure was usually observed in the sodium ion (figure 5.35). The Dai research group
also discovered a new confonnation, mixed hybrid structures, in the human telomeric
intennolecular G- quadruplex structure.323 Miyoshi and his research team has report the
structural transition from antiparallel to parallel ofG-quadruplex of d(G4T4G4) induced
by calcium ion ( figure 5.36).
The CD spectra ofPEIIDNA (5 to 1) initial time profile (see Figure 5.34) showed a
positive peak at 260 nm and two negative peaks at - 240 nm and -285 nm, still a classic
parallel quadruplex confonnation. The four hours CD spectra ofPEIIquadruplex DNA (5
to I ratio) showed two positive peaks at - 230 nm and - 260 nm and a weak negative
peak at - 285 nm. In comparing with the typical CD spectra of the parallel and
antiparallel strands, the PEII (T4G4)4 DNA (5 to 1) existed some peaks in both
confonnations (230 nm and 260 nm).

331
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Reviewing these results, all suggest that, most probably, in the high molar ratio of
PEl (5 to I) might induce a structural transition of the G-quadruplex (T4G4) DNA from
parallel (the original T4G4 is a parallel confonnation) to another confonnation (hybrid or
antiparallel) or to a mixture of different structures.

Figure 5.34: CD spectra of the PEIIquadruplex T 4G4 DNA (5 to 1 molar ratio)
Structural Transition ProfIle As a function of time
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Figure 5.35:

CD Spectra of Hybrid G-quadruplex DNA in the presence of the
Potassium, Sodium and Ammonium Cation
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Image adapted from Smargiasso N., et a1. BMC Genomics 2009, 10(362),
10.1186/1471-2164-10-362.

Figure 5.36: CD Spectra of the Transition from the Antiparallel to the Parallel
G-quadruplex.
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As we assess the NMR and CD results, we cannot conclusively assign the
confonnation of the G-quadruplex T4G4 structures in the presence of PEl at this point.
The structural transitions are quite complex, and there are multiple variables:
concentration (ratio) of PEl with respect to DNA, time, and temperature. As shown in
figure 5.36, the nature of the cation can greatly change the quadruplex structure, however
addition of PEl replaces the potassium and any sodium cations with the alkyl ammonium
ions of the PEl would induce the confonnational change. The structural rearrangements
may be occurring slowly but continuously, with equilibration between parallel, mixed 3: I
and antiparallel structures. There is no doubt that the temperature will strongly effect the
structural confonnation and transition status. All the experimental data reported here
provide some infonnation on the structural transition induced by PEl in quadruplex
(T4G4) DNA, but significant work is required to fully elucidate the solution to this
problem.
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CHAPTER 6
6.1

SUMMARY, CONCULSION AND FURTHER STUDY

Summary and Conclusion
The purpose of this study was to discover and examine polymers which bind DNA

for nucleic acid research. We were not entirely successful on our original plan (binding 
crosslinking - imprinting), but have made significant advances which prepare the way for
future work.
We have demonstrated that cross-linking of PEl with isophthalaldehyde occurred
both in solution and in bulk. For solution cross-linking, the light scattering results did not
show any increase in molecular radii. Instead, there was a trend of a slight decrease in
radii, which suggests that the PEl might have "shrunk" through intra-molecular cross
linking. When isophthalaldehyde reacts with two polyethylenimine (PEl) (-NH2) groups,
the branches of the PEl will connect through the isophthalaldehyde.
This intra- molecular cross-linked reaction might slightly decrease the
hydrodynamic radius of the PEl because the molecule will become more compact. The
light scattering data showed that the PEl molecule did not develop the molecular
aggregation behavior up to a concentration of 1.8 M. It can be concluded that intra
molecular cross-links were formed within PEl branched polymers. Furthermore, the data
suggested that PEl cross-linking can produce the optimal condensation effect and
decrease the molecular radii ofthe PEl which might improve the biological application of
polyethylenimine.
The In Situ NMR and UV extraction data also showed that isophthalaldehyde was
incorporated into the PEl by chemical cross-linking. This part ofthe study proves that
isophthalaldehyde, a cross-linking agent, was found to be effective in forming
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cross-linked with PEl.
Our CD data agreed with the literature that quadruplex DNA (T4G4)4 is a parallel
conformation. CD titration results showed that by adding PEI!quadruplex (T4G4) DNA
complex into quadruplex (T4G4) DNA at very low concentration ofPEI, the quadruplex
DNA still maintains a parallel quadruplex structure. By adding more and more PEl into
quadruplex DNA, however, the DNA went through a structural change.
In response to this, we performed the CD melting study to investigate the binding
phenomena of the (T4G4)4. However, CD melting did not yield any conclusive data.
Other researchers' data indicate that quadruplex (T4G4) DNA melts at a very high
temperature (closer to 100°C). Therefore, it is difficult to observe conclusive results
(melting data was not shown).
As shown in the CD spectra, the initial results of the PEI! quadruplex (T4G4) DNA
complexes suggested that PEl might denature quadruplex DNA, and convert it into new
structures as a result of strong interactions between the cationic PEl and anionic DNA
chains. This impacted the possibility of whether we could template PEI by cross-linking
it in the presence of quadruplex DNA. This loss of quadruplex structure questioned our
use of the PEI!isophthalaldehyde system for imprinting on quadruplex DNA. It also
points to the difficulties of importing any less robust DNA structure into cells using PEL
We then examined other polymers as potential imprinting media.
The finding of other polymers with the capability of more applications in the
biomedical field has raised some concerns.

We studied the interaction of some cationic

and neutral polymers with quadruplex (T4G4) DNA. The cationic porphyrin (TMPyP4)
was selected as a probe to investigate the interaction of the polymers and quadruplex
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(T4G4) DNA. TMPyP4 has been reported to have a high affinity to quadruplex DNA due
to its similar size with quadruplex DNA.

The preliminary polymer screening results

showed that the neutral polymers interact with quadruplex DNA without displacing the
porphyrin. The porphyrin UV spectrum peak maximum shifts from 422nm to 433 nm
remained after adding those polymers.
The polyethylenimine (PEl) binds to quadruplex DNA by electrostatic attraction.
The CD and porphyrin UV screening results showed PEl might alter the quadruplex
DNA structures.

Other researchers have shown that polyvinylpyrrolidone is able to bind

to DNA. In contrast to free quadruplex DNA, the polyvinylpyrrolidone (PVP), some
changes were observed in 3lp NMR of quadruplex DNA-binding interaction. By adding a
sufficient amount of the compounds, we have observed the 3lp NMR spectra shifted to a
higher frequency field (down field). A slight change of polyvinylpyridine N-oxide
(PVNO) was also observed in 31p NMR of quadruplex DNA-binding interaction.
Diffusion NMR is a very powerful tool to study mobility of molecules and to
characterize mixtures of the complex in the biochemistry fields. Our NMR data from the
diffusion experiment has indicated that the poly(N-vinylpyrrolidone) has shown the
binding interaction with the quadruplex (T4G4) DNA which is consistent with the
previous finding. The poly(4-vinylpyridine N-oxide) did show a weak binding
interaction with the quadruplex (T4G4) DNA.
However, the interaction ofthe quadruplex DNA with PVNO is still unclear at this
moment. Although it is not as well-defined as indicated by the lack of well resolved
NMR peak for PVP and PVNO polymers, we still can provide some information for
applying these polymers in further studies.
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In attempt to better predict the binding interaction for poly(ethylenimine), poly(N

vinylpyrrolidone), and poly(4-vinylpyridine N-oxide) with quadruplex (T4G4) DNA; we
have conducted the DOSY NMR experiments. The DOSY data verified the same
conclusion as the previous NMR studies for these three polymers. Moreover, we have
discovered the binding ratio ofthe PVP and quadruplex DNA, as indicated in the
experiment, I to I binding ratio showed very weak binding or some kinds of interaction.
The 5 to I ratio showed the better binding affinity and 10: 1 ratio was shown many
fragment peaks which indicated the conformational changing in quadruplexes DNA.
A 2D NOESY experiment was performed to further investigate the conformational
change on binding of the poly (ethylenimine) with quadruplex (T4G4) DNA. We
therefore conclude that molar ratio of PEl Iquadruplex DNA at 5 to 1 has stronger
binding interaction than at a I to 1 ratio. The PEIIquadruplex DNA structural transition
was also investigated by CD; the CD spectra show that PEl will induce the
conformational change in quadruplex DNA structures. However, the definitive
conformation has yet to be determined by our studies.
A number of challenges still remain unfulfilled in fully understanding the
importance of these materials. Further study will continue to develop the suitable
functionalized polymers and hope to provide guidance to other researchers and for a
better understanding and applying in using these materials in nucleic acid research.
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6.2

Suggested Further Studies
Building on these results, further studies in this area will seek to extend the

structure-function relationship of quadruplex DNA and its applications. Our research has
revealed some preliminary fmdings about quadruplex T4G4 DNA binding to PEL
We hope to find more specific information about the mechanism of the transition steps
does this transition in multiple steps or is it a single step transition? Is there a single PEl
induced structure or is there a dynamic equilibrium between a suite of structures? Is the
structural alteration by PEl general- will all quadruplex structures be altered - or
specific to parallel structures? Can we use the similar sequences with an antiparallel
structure to cross-links with PEl and apply this architecture to the imprint techniques.
We will evaluate the sequences and structures availability for the improving the binding
specificity with G-quadruplex DNA.
The other interests are in the modification of the porphyrin and its derivatives. Based
on porphyrin end-stacking property with G-quadruplex, derivative of porphyrins can
conjugate with polymers or other small molecules could possible induce quadruplex.
Further improvement will continuously rely on a better understanding of the cellular
and in vivo barriers in gene transfer. We anticipate that significantly improve the structure
specificity will provide new insights into the direction of future research.
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